The 2023 IDPHSB Center for HIV Prevention and Health Services Integrated Statewide Meeting: "Mobilizing Our Efforts for Outcomes-Based Success" took place virtually on Friday, November 3, 2023 from 9:00 AM to 4:30 PM Eastern.
HealthHIV Learning Management System
Search results: 185
**This course is no longer offering CE credits.**
This module examines three related non-pharmacological approaches to pain management. The module will discuss relevant benefits and risks associated with these therapies. Additionally, the module provides health professionals with the ability to integrate these approaches into their practice and knowledge of which patients are good candidates for these types of pain treatments.
Learning Objectives
- Explain the risks and benefits of acupuncture and massage therapies
- Explain the role of acupuncture and massage in comprehensive pain management
- Name three (3) conditions for which acupuncture is recommended in practice guidelines
- Describe two (2) self care techniques
This Module is addressing the aging population of people living with HIV in the Ryan White community with a look at Washington DC. In the presentation, you will note aging, older than 50, and older than 55 are used interchangeably. In some cases that data looked at a populations over 55.
Faculty: Jim Williams, B.A.
Contact Information: HAHSTACBAPrograms@dc.gov
Young people living with HIV (PLWHIV) are at an increased risk for developing mental health disorders than people not living with HIV. PLWHIV commonly internalize negative attitudes and beliefs resulting from widespread HIV stigma, which leads to poor mental health outcomes and difficulty medically managing HIV. Challenges in mental health can negatively affect engagement in medical care and adherence to medical treatment.
This module aims to increase the audience’s understanding of mental health challenges of children, adolescents, and young adults living with HIV and to provide ways to address their particular needs and promote overall physical and mental health
Start Date: 7/27/2023Expiration Date: 7/27/2024
UAN#: JA4008162-9999-23-278-L02-P
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.Educational Objectives
After completing this activity, the participant should be better able to:
- Describe at least three common mental health challenges that children, adolescents, and young adults face when living with HIV.
- List how mental health challenges can impact their medical care and treatment.
- Identify at least three ways to address the particular mental health challenges that children, adolescents, and young adults living with HIV face to improve their self-perceived health and reception of medical treatment.
Faculty
Gretchen Cruz Figueroa, PsyDDisclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high-quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenters have nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hour.Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 Clinical continuing education credits.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.This course is jointly provided by Postgraduate Institute for Medicine (PIM) and HealthHIV.
Please review the content below at your own pace.
NOTE: If you seek continuing education credits (CEUs) from PIM after completing the module, you will go to their website and complete a post-course check and an evaluation. If you will not seek credits, you will not need to take a post-course check, but please complete the non-credit evaluation at the end of the module. Whether or not you seek credits, you do not need to take a pre-course check and can go straight to the presentation.
Release Date: August 24, 2023
Expiration Date: August 24, 2024
UAN: JA4008162-9999-23-292-L02-P
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Educational Objectives
After completing this activity, the participant should be better able to:
- Identify how terminology used in health care settings can impact quality of care.
- Recognize the impact of stigmatizing terms and phrases used in medical charts.
- Explain the impact of stigmatizing language in the workplace.
Faculty
Valerie Wojciechowicz
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenter has nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
There are gaps in understanding the changing demographics of people with HIV, as well as gaps in understanding the impact of aging on co-morbidities in people with HIV. This webinar reviews the current epidemiology of HIV, identifies key points of HIV and aging, and discusses the impact of the aging population and co-morbidities on HIV.
Faculty: Dr. John Hogan
Please review the content below at your own pace.
**NOTE: This course is no longer offering CE credits.**
This session provides a non-clinical view of harm reduction, with a particular focus on its intersection with aging. The presenter draws upon her lived experiences from layered perspectives on substance use, mental well-being, HIV, and aging to review models and techniques supporting informed decision-making to define one's personal view of harm reduction. The presentation includes a discussion of some behaviors that support as well as hinder smooth sustainability across one's lifespan.
Learning Objectives:
At the end of this webinar, you will be able to:
- Discuss diverse views of harm reduction.
- Define principles of harm reduction as they apply to aging.
- Develop a multifaceted harm reduction plan with a focus on clients who are aging.
Faculty: Linda Scruggs, MHS, LPC, SME
NOTE: This module does NOT offer continuing education credits.
Aging with HIV Institute
Providers and Practitioners on the State of HIV Care Coordination
By 2030, nearly 75% of all people living with HIV (PWH) in the US will be aged 50 and older. 84% will most likely have at least one (1) additional comorbidity; 28% will have three (3)—compared with only 19% of those not living with HIV. And while older PWH have shown higher rates of service engagement compared with their younger counterparts, the successes prolonging “physical” health is undermining other aspects of successful aging with HIV and their interventions. Together with community leaders, provider participants will discuss and frame their shared experience conversations into adaptive and innovative recommendations and evidence-based interventions that reduce disability and improve service delivery for PAWH.
Aging With HIV Roundtable: Care Coordination Includes Enhanced Quality of Life
With improved access to antiretrovirals, people are now aging and living longer with HIV (PAWH). While the care cascade highlights our shared medical successes, it doesn’t show the entire picture of the true “costs” of graying of HIV. In fact, health systems often overlook the underlying problem of HIV’s distinctiveness—especially as we age. In an increasingly bio-medicalized context of care delivery, what does successful aging with HIV look like? This roundtable brings together people living and aging with HIV (15 years or more) to review and reflect upon the current capacity and future constraints of the HIV and aging care and prevention services sectors, and the discrete needs that follow.
SPEAKERS
Tez Anderson, Let’s Kick ASS
Jon Appelbaum, Florida State University College of Medicine
Scott Bertani, Director of Advocacy for HealthHIV
Michelle Lopez, Healthy Aging Specialist at GMHC
Donna Sweet, University of Kansas School of Medicine
Val Wojciechowicz, Medical Peer Program Manager at Community AIDS Network/CAN Community Health
Visit sync2021.org/credits for information on claiming and receiving CME/CE credits for this session.**THIS COURSE IS NO LONGER OFFERING CE CREDITS**
TelePrEP is a service that provides pre-exposure prophylaxis (PrEP) medication to individuals at risk of contracting HIV via remote telemedicine appointments. It allows patients to receive PrEP medication and support from a healthcare provider without having to visit a clinic in person, making it more convenient and accessible.
TelePrEP in Practice is a webinar that covers the benefits of telePrEP, as well as strategies and best practices for integrating telePrEP into your organization's services.
Release Date: May 17, 2023
Expiration Date: May 17, 2024
UAN# JA4008162-9999-23-231-H02-P
Target Audience
This activity is intended for the following professionals practicing in the state of Maryland: Physician, PA, Registered Nurse, Nurse Practitioner/APRN, Pharmacist, Psychologist, Social Worker, Dentist.Educational Objectives
After completing this activity, the participant should be better able to:
- Discuss how telehealth has transformed access to quality HIV prevention services.
- Identify aspects of provider readiness to deliver telePrEP, including availability of telehealth technical resources for providers.
- Describe opportunities and strategies to leverage existing resources and infrastructure development to support the extension/utilization of telehealth services for PrEP by the healthcare team.
- Describe model practices for the delivery of effective and engaging telePrEP services, including hybrid (in-person and virtual) models.
Faculty
Christopher Hall, MD, MS, AAHIVS and Keith TaylorDisclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high-quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenters have nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hour.Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 Clinical continuing education credits.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.The Testing and Linkage to Care curriculum is composed of a self-paced elearning course and 5 self-paced webinars on HIV testing topics. Learners must complete the self-paced course and all four self-paced webinars to complete the curriculum and enroll in the HIV Testing Skills Assessment.
This course is only available for learners/testers who are based in Maryland. If you believe you should be able to access the course and cannot please email eLearning@healthhiv.org.
- Manager: Leo Sheridan
Harm reduction meets people wherever they are ready to begin their positive change journeys, supports the full range of positive change goals and emphasizes empowerment and collaboration between therapist and client. Drawing on relational, psychodynamic, cognitive-behavioral and mindfulness therapies, IHRP techniques are uniquely tailored to each person. A central focus on therapeutic alliance and relationship creates a safe context in which to clarify the meanings and functions of risky and addictive behavior, enhance self-regulation and develop alternative healthier, self-affirming solutions. Tatarsky will discuss harm reduction’s core principles, the limitations of traditional disease model based abstinence-only treatment, IHRP’s clinical rationale, supporting biopsychosocial theory and seven therapeutic tasks.
Faculty: Andrew Tatarsky, PhD
Original Recording Date: 8/29/22
NOTE: This module does NOT award credits.Course Description: This presentation discusses HCV stigmatization, barriers to HCV care, provider and patient education efforts with respect to HCV, different prevention approaches for HCV, how HCV works biologically and scientifically, geographic, chronological, and demographic trends in HCV transmission, risk factors for HCV transmission, the effects of HCV on the body, HCV treatment options, HCV testing, HCV legal and medical guidelines, and recent and upcoming advances in HCV treatment and prevention.
This course is jointly provided by Postgraduate Institute for Medicine and HealthHIV.
Please review the content below at your own pace.
Release Date: 9/25/23
Expiration Date: 9/25/24
UAN: JA4008162-9999-23-326-L02-P
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Educational Objectives
After completing this activity, the participant should be better able to:
- Analyze Hepatitis C demographics to identify hidden patterns and target high-risk populations effectively.
- Describe the revolutionary impact of direct-acting antivirals (DAAs) on Hepatitis C treatment outcomes.
- Explain the significance of universal HCV testing in reducing transmission rates and enhancing public health outcomes.
- Discuss the rationale behind universal HCV treatment and its role in reducing disease burden.
- Navigate simplified HCV treatment guidelines and apply them to patient-centered approaches.
- Evaluate strategies for treating and preventing HCV transmission, focusing on high-risk populations and overcoming barriers to care.
Faculty
- Allyson L. Ishihara, MSW, LCSWA - Licensed Clinical Social Worker at Wake County Health & Human Services - Division of Public Health
- Professor Mark Sulkowski, M.D., Johns Hopkins University School of Medicine, Baltimore, USA
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
Dr. Mark Sulkowski disclosed that he had received research grants from Janssen, Vir, and AbbVie, over the course of his work at Johns Hopkins, that he had received consulting fees from AbbVie, Aligos, Atea, Gilead, Precision Bio, GSK, and Virion, pursuant to serving as a Scientific Advisory Board member related to HBV, SARS-CoV-2 and HCV, that he had received personal payments related to work for Gilead and Immunocore, on DSMB related to HIV and HBV, and that he had received personal payments for his role on Journal Viral Hepatitis as the American Editor.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This webinar will provide participants with an overview of how to apply harm reduction principles for people who use drugs (PWUD) to the context of sexual health and relationships. The faculty will review how practicing harm reduction within sexual relationships between PWUD can reduce the risk of HIV, HCV, and other sexually transmissible infections. Participants will learn how to identify possible sexual risk scenarios for their clients, as well as how to discuss sexual harm reduction with clients with the goal of enhancing and maintaining overall health.
Learning Objectives:
At the end of this webinar, you will be able to:
- Apply harm reduction principles to sexual health contexts.
- Identify scenarios that may increase drug-using clients’ risk of infectious disease transmission and acquisition.
- Discuss sexual risk reduction with clients in a manner that is authentic and inclusive.
- Create sexual harm reduction plans that are tailored to clients’ needs.
Faculty:
Mark Robinson, Regional Syringe Service Program Manager for Family and Medical Counseling Service, Inc.
Monica S. Ruiz, PhD, MPH is an Associate Professor in the Department of Prevention and Community Health, Milken Institute School of Public Health, George Washington University (GWU)
Integrating biomedical interventions into practice is a key component of ending the HIV epidemic. Providers must communicate effectively with clients to inform them of scientifically-supported interventions, ensuring client understanding and addressing client concerns. This session will cover the 10 most common myths about PrEP, discuss a PrEP patient survey, and highlight several PrEP marketing efforts to engage clients. Identify the 10 most common myths preventing PrEP uptake in the U.S. Emphasize need to be fact-based and data-driven in one's communication with their patients and communities Discuss the PrEP program at the Virginia Department of Health Discuss the results and implications of the PrEP Patient Survey Describe best strategies for reaching specific communities (MSM, African-American, Latinx, trans, cis-gender female). Discuss incorporating humor and sex-positivity into marketing collateral
Learning Objectives:
**THIS COURSE NO LONGER OFFERS CE CREDITS**
This course is jointly provided by Postgraduate Institute for Medicine and HealthHIV.
Please review the content below at your own pace.
Release Date: May 30, 2023
Expiration Date: May 30, 2024
UAN: JA4008162-9999-23-233-L02-P
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Educational Objectives
After completing this activity, the participant should be better able to:
- Outline HIV and PrEP disparities in the United States.
- Explain the importance of utilizing a status neutral approach in order to End the HIV Epidemic in the United States.
- Summarize current HIV prevention and treatment formulations and guidelines.
- Review common side effects of PrEP and HIV treatment.
- Identify barriers and opportunities to increase PrEP uptake and retain persons living with HIV in care.
Faculty
Tyris D. Ford, DNP, NP-C, FNP-BC, AAHIVS
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenter has nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This webinar seamlessly combines theory and practice to empower participants with the essentials of outreach and secondary exchange. Delve into the significance of these approaches and the common barriers faced in their implementation. Discover highly effective strategies for outreach, recruitment, and engagement. Recognize the indispensable role of People Who Use Lived Experience (PWLE) in all aspects of Syringe Services Programs (SSPs). Additionally, gain valuable insights into available SSP resources in the DC area, ensuring comprehensive and inclusive care provision.
Learning Objectives:
Upon completion of this webinar, participants will be able to:
- Acquire foundational knowledge in outreach and secondary exchange methods.
- Gain a nuanced understanding of the significance of outreach and secondary exchange, while identifying and addressing associated barriers.
- Master highly effective strategies for conducting outreach and maximizing recruitment engagement.
- Recognize the pivotal role of involving People Who Use Lived Experience (PWLE) in all facets of SSPs.
- Become familiar with the available SSP resources within the DC area.
Faculty: Carolina Diaz, ACR Health and Elizabeth Wright, ACR Health
NOTE: This module does NOT offer continuing education credits.
This webinar will provide participants with an overview of the essential components of budgeting and fiscal health for Maryland providers.
Learning Objectives
At the conclusion of this session, you will be able to:
Explain why budgeting is important.
Identify the common types of budgets (operating budget and capital budget).
Describe budget components (revenue and income).
Create a contingency plan.
Identify bookkeeping best practices.
Develop budget justification.
| |||
This webinar will provide participants insights and strategies for engaging stakeholder organizations. Faculty will discuss how to identify stakeholders, develop long-lasting and mutually-beneficial partnerships, and work in sync to uplift the communities you serve.
Faculty: Kenya Hutton, Deputy Director, Center for Black Equity
Learning Objectives:
- Understand the importance of stakeholder identification in community engagement and its impact on project success.
- Learn effective strategies for identifying key stakeholders and assessing their needs and interests.
- Enhance communication skills to effectively convey messages and gather feedback from stakeholders.
- Gain insights into driving positive outcomes through stakeholder engagement and fostering collaboration within the community.
- Acquire practical tools and resources for building strong connections and fostering a sense of community ownership in projects.
Release Date: May 1, 2024
Note: Continuing education credits are not available for this webinar.
This webinar is tailored for healthcare professionals and their supporters seeking to optimize Pre-Exposure Prophylaxis (PrEP) implementation. This session delves into identifying ideal PrEP candidates, linking and retaining clients effectively, and addressing prevalent barriers to PrEP access. Attendees will gain practical insights and strategies to enhance their PrEP navigation skills, ultimately contributing to more effective HIV prevention efforts
Release Date: January 24, 2024
Expiration Date: January 24, 2025
UAN: JA4008162-9999-23-110-H02-PTarget Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Educational Objectives
After completing this activity, the participant should be better able to:
- Identify the ideal PrEP candidate
- Recognize how to link and retain clients
- Identify barriers to PrEP
- List resources to PrEP
Faculty
Dr. Immerine Monet Ouwinga, MD, Board Certified Family Medicine, CCI Greenway Program and Medical Director of Title X
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenter has nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
TThe maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0. 10 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1.0 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Track Description:
This session recognizes the need for the quality mental health services for people with HIV (PWH). Integrating behavioral health services into primary and specialty care can lead to better health outcomes for PWH. Practical integration and implementation of such activities requires intentional quality improvement (QI) activities.
Track Learning Objectives:
Detail the process for improving accessibility of MH services by conducting an interest or needs assessment.
Identify a framework that applies practical implementation science ideas to enhance the QI process.
Describe use of at least two (2) existing QI tools and performance measures
Discuss the process of the developing new QI tools for behavioral health integration.
Describe how the Learning Collaborative model and practice facilitation coaching has been used to support agencies along the transformation journey.
Assess the importance of behavioral health integration across clinical settings.
Session #1: Behavioral Health Integration
Session Title: Meaningful Integration of Behavioral Health Services
Session Description:
This session recognizes the need for the quality mental health services for people with HIV (PWH). Integrating behavioral health services into primary and specialty care can lead to better health outcomes for PWH. Practical integration and implementation of such activities requires intentional quality improvement (QI) activities.
Session Learning Objectives:
Detail the process for improving accessibility of MH services by conducting an interest or needs assessment.
Identify a framework that applies practical implementation science ideas to enhance the QI process.
Describe use of at least two (2) existing QI tools and performance measures
Discuss the process of the developing new QI tools for behavioral health integration.
Describe how the Learning Collaborative model and practice facilitation coaching has been used to support agencies along the transformation journey.
Assess the importance of behavioral health integration across clinical settings.
Session #2: Methods for Enhancing Viral Suppression
Session Title: Innovative Methods for Promoting Viral Suppression
Session Description:
Continuous Quality Improvement (CQI) strategies implemented in HIV programs have had tremendous impacts on viral suppression and other health outcomes. This session will assess historic gains from CQI/QI methods, explore the application of such methods to a variety of programs, and interrogate lessons learned from these processes. The session will additionally address the use of QI collaborative frameworks intended to address health disparities.
Session Learning Objectives:
Discuss how QI methodologies are used to implement improvement interventions to impact the HIV epidemic, and how they can be applied in a variety of HIV healthcare settings.
Identify two (2) best practices and two (2) common challenges from the experiences of regional, state-wide, and national collaborative QI improvement activities.
Describe how CQI processes have advanced the quality of care.
Discuss monitoring activities utilized to assess innovative interventions encouraging viral suppression.
Session #3: Improving Clinical Outcomes
Session Title: Innovative Practices for Complex Problems: Engaging and Retaining Priority Populations
Session Description:
Adequately addressing priority populations with tailored interventions and health promotion messages is key to ending the HIV epidemic. This session will explore innovative practices in building HIV self-management skills, transforming healthcare settings to encourage adherence to HIV medications, evidence-based daily medication reminders for young men of color in Chicago, and programs that support victims of domestic minor human trafficking.
Session Learning Objectives:
Describe how a medical home model provides an innovative approach in providing needed medical and mental care for exploited youth.
Discuss project recruitment strategies for an array of priority populations.
Detail considerations in the development of tailoring health promotion messages.
Describe roles of health professionals within multidisciplinary teams in engaging new patient populations.
Session #4: Expanding a Healthy Workforce
Session Title: Caring for Your Community: Supporting a Healthy HIV Workforce
Session Description:
Professionals working on HIV-related health interventions and initiatives are dedicated individuals with long-term connections to their work. This level of connection breeds an innovative, committed workforce with many of its members relating with beneficiaries due to common lived experiences. This session will explore how to harness the close connections health professionals have with their work in this field, demonstrating the need for peer-led programs, ethical considerations for practitioners providing services close to home, and initiatives aimed at increasing resiliency among the HIV workforce.
Session Learning Objectives:
Discuss the impacts of counter-transference around intersectionality, experiences, and identity while serving patients with similar backgrounds.
Assess factors that contribute to health care workers burnout.
List at least three (3) individual-level strategies that build the resilience of health care workers.
Identify two (2) online resources to support engaging with others with empathy while avoiding burnout.
Identity three (3) empirically-driven tools to prevent vicarious trauma in the workplace.
Discuss a state-wide peer model aimed at improving patient experience through engaging and training community members as community health workers.
Welcome to Cocaine and Methamphetamine Stimulant Use: Strategies for Addressing Acute Intoxication and Withdrawal.
Please review the content below at your own pace.
**This course is no longer offering CE credits.**
This module introduces two non-pharmacological approaches for addressing pain: CBT and mind-body techniques. These techniques are examined for effectiveness and explored in depth to enable learners to utilize these approaches in practice.
**This course is no longer offering CE credits.**
Learning Objectives
- List three (3) mind body strategies that are helpful for pain patients
- Instruct a patient in one breathing exercise
- Describe central sensitization and indicate three (3) risk factors that predispose an individual to it
Course Description: This webinar will enhance the understanding of positive and negative forms of de-escalation, conflict resolution, and crisis intervention strategies for purposes of reinforcing community-focused harm reduction strategies. Additionally, it will dive into the barriers, strategies, and communication methods that will aid in creating a supportive environment for community members.
Faculty: Dr. Ashley Elliott
Learning Objectives:
After participating in this webinar attendees are expected to:
Identify 1-3 barriers impacting communication with consumers/community members
Provide practical examples of positive intervention strategies for low-risk, medium-risk, and high-risk consumers/community members
Demonstrate understanding of the intervention terminology and provider roles in order to effectively support community members and create clear lines of communication between community members and community agencies
This insightful webinar will guide you through the crucial steps in accessing substance use disorder (SUD) treatment spaces. Gain a nuanced understanding of the diverse range of SUD treatment options available within the continuum of care. Learn to discern the right candidates for referral to these programs and develop effective communication strategies for facilitating these crucial conversations. We'll explore the pivotal role of sustained, open-ended discussions in the context of SUD treatment, and recognize the invaluable perspectives brought by People Who Use Lived Experience (PWLE) to this process. Prepare to enhance your proficiency in bridging the gap to SUD treatment spaces and providing essential support to those in need.
Learning Objectives
Upon completion of this webinar, participants will be able to:
Define and differentiate SUD treatment spaces within the continuum of care.
Identify the appropriate candidates for referral to SUD treatment programs.
Develop effective communication strategies for discussing and referring patients to SUD treatment services.
Locate nearby SUD treatment spaces for seamless patient referrals.
Appreciate the significance of sustained, open-ended discussions in the context of SUD treatment, and recognize the unique value that People Who Use Lived Experience (PWLE) bring to this process.
Faculty: Carolina Diaz, ACR Health & Elizabeth Wright, ACR Health
This course is jointly provided by Postgraduate Institute for Medicine and HealthHIV.
Please review the content below at your own pace.
Release Date: August 8, 2023
Expiration Date: August 8, 2024
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Educational Objectives
After completing this activity, the participant should be better able to:
- Recognize the signs and symptoms of mental health challenges.
- Describe the influences of cultural and societal stigmas on help-seeking behaviors.
- List the barriers to treating depression that are unique to men of color.
- Identify empathetic language to help others facing mental health challenges.
- Identify appropriate mental health support and substance use services.
Faculty
Patrick LeBlanc
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenter has nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Data to Action: Using Data to Initiate and Inform HIV/STI Client Services and Public Health Response
This webinar illuminates how HIV/STI surveillance and program data are used to initiate and inform client services and public health response. After defining "data to action" and reviewing the core data sources in Maryland, attendees will learn how data reporting and analysis lead to real-time field services and care engagement support for several groups of people: those newly diagnosed with HIV or syphilis, those living with HIV who may not be fully engaged in HIV medical care, and those who may benefit from HIV/STI testing, treatment, and prevention services. Faculty also will discuss core principles of confidentiality and person-first services, review how trend and network analysis inform public health response, and emphasize how clients, providers, and community members are key partners in HIV/STI data to action.
Faculty:
Alyssa Arey Risney, MPH
Brittany Battle, MHA
Hope Cassidy-Stewart, MHS
Learning Objectives:
At the end of this webinar, you will be able to:
- Describe data to action as a public health strategy and Maryland’s data to action activities.
- Understand the role of HIV/STI surveillance data and other core data sources in data to action.
- Explain methods for implementing client- and community-level data to action that ensure confidentiality and reduce stigma.
- State how clients, providers, and community members can partner with public health to achieve the goals of HIV/STI data to action.
Note: There are no credits available for this activity.
This session explores the impact of stigma on people who have been diagnosed with substance use disorder (SUD) and those who are not clinically diagnosed but display symptoms. The presenter examines the relationship between stigma and systemic racism, as well as racism's compounding effect on access to healthcare services for people who use drugs. The presenter also provides strategies for challenging stigma and misconceptions about SUD.
Faculty: Mark Robinson
Learning Objectives:
At the end of this session, you will be able to:
- Describe stigma and the impact it has on people who use drugs.
- Identify how trauma, racial injustice, and historical social constructs have affected communities.
- Describe ways to respond to drug-use stigma in the workplace and society.
NOTE: This session does NOT offer continuing education credits.
Facilitators
Sharday Lewis, NASTAD
Dr. Tamara Henry, GWU Milken Institute School of Public HealthScenario Discussion 1: How can we combat stigma and educate neighborhood businesses and the immediate community about the need for HR Vending machines? What are the pros and cons of Supervised Consumption Services within a community?
Scenario Discussion 2: How can CHW’s assist in bridging the gaps in Trans syndemic clinical environments? What methods can be incorporated for Trans communities to be more involved in Harm Reduction dialogues?
Objectives
Exploring the nuances of pre-existing conditions and coping drug use
Defining the "Right to Treat" laws of EMTALA and how this can protect syndemic drug user Health.
Note: This session does not offer continuing education credits.
Please review the content below at your own pace.
**NOTE: This course is no longer offering CE credits.**
After completing this activity, the participant should be better able to:
- Identify qualitative data for the development of population-based HIV interventions.
- Explain HIV/STI trends among women in the DC area using surveillance reports.
- Identify social barriers to HIV care for women.
- Describe trauma-informed approaches for women in HIV care.
- Identify HIV support services to women in DC.
Faculty: Corey Beauford, LICSW, LCSW-C
Owner, Inspired Consulting Group
Clinical Instructor with the University of Maryland School of Social Work
Mental Health 101: Social workers, case managers, and other counselors face significant challenges in working with people living with HIV (PLWH) and their families. HIV-affected populations typically require a full range of services to manage the illness and the significant stress and problems HIV causes. Service needs are increased when clients have mental health problems in addition to living with HIV. This training will give an overview of various mental illnesses, signs and symptoms, and treatment options.
After completing this activity, the participant should be better able to:
- Understand general knowledge on diagnostic criteria for selected mental and substance use disorders
- Identify various factors, including cultural factors, that contribute to a patient being diagnosed with a mental or substance use disorder.
- Discuss treatment considerations – including psychopharmacology - specific to patients with mental and substance use disorders.
- Understand the impact that countertransference and transference can have on the therapeutic relationship and identify strategies useful for resolving worker biases.
Case Management Best Practices Toolkit: This webinar discusses the Case Manager Best Practices toolkit which includes treatment protocols, models of care coordination, challenges and how to address them, and an integrated team approach.
After completing this activity, the participant should be better able to:
- Define the duties of a Care Coordinator and Case Manager
- Define and describe Treatment Improvement Protocols established by CSAT outlining the roles of a Care Coordinator
- Identify strategies useful for addressing common client psychosocial needs
- Explain the “Integrated Treatment Team Approach.”
This required training will introduce the concept of intersectionality and discuss the interconnected nature of social categorizations such as race, class, and gender as they apply to a given individual or group, specifically those living with HIV/AIDS. The impact of intersectionality and Social Determinants of Health on health outcomes will be addressed, followed by analysis of a case study in small breakout groups.
This course is jointly provided by Postgraduate Institute for Medicine and HealthHIV.Please review the content below at your own pace.
Release Date: January 24, 2024
Expiration Date: January 24, 2025
UAN number: JA4008162-9999-24-043-H02-P
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Educational Objectives
After completing this activity, the participant should be better able to:
- Identify the layers and complexity of Intersectionality
- Describe the racial inequities that arise from social determinants of health and health equity
- Summarize the effects of social determinants on people living with HIV/AIDS.
- Examine strategies for identifying, addressing, and preventing implicit bias in order to facilitate retention in HIV care.
- Review barriers to care for populations affected by social determinants of health.
- Identify resources to address social determinants of health and empower people living with HIV/AIDS
Faculty
Karen Guillory LICSW, CCTP, C-DBT
Director of Social Services, Unity Health Care
Michelle LeVere
Clinical Instructor, University of the District of Columbia
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenter has nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 2 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 2 contact hour(s) (0.2 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 2 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 2 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 2 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This offering covers how the effects of various social determinants of health affect both intimate partner violence and the spread of HIV.
Please review the content below at your own pace.
Release Date: April 6, 2023
Educational Objectives:
- Define sexual violence and consent
- Identify risk factors for contracting HIV through rape
- Discuss the incidence and prevalence of intimate partner violence in select populations
- Describe a multidisciplinary approach to IPV prevention
- Describe evidence based efforts to mitigate the effects of intimate partner violence
**This course is no longer offering CE credits.**
This module will discuss the core characteristics, core practices, and emergent qualities that enable inspiring leadership in organizations and lives.
Community-based organizations (CBOs) are integral to achieving the goal of Ending the HIV epidemic (EHE). Their familiarity with and location within communities disproportionately impacted by HIV allow these organizations to directly address determinants of health through formal and informal medical and social services. However, community awareness of these services is essential for their success, as well as for your CBO's organizational sustainability. This webinar will discuss best practices for cost-effective marketing and branding, along with strategies for measuring the impact of these campaigns.
Faculty: Elana I. Ahiati MPH, MS and Mark Young, MBALearning Objectives:
- Describe strategies for crafting media messages that promote the HIV care continuum.
- Identify best practices to promote HIV prevention and treatment messages that engage the community.
- Describe the importance of putting “emotional intelligence" into healthcare marketing.
- Explain methods to measure the impact of your marketing campaign.
Note: This course does not offer continuing education credit.
La comunidad latina/x está formada por diversas poblaciones que a menudo experimentan barreras para acceder a una atención y unos servicios para el VIH equitativos. Esto conduce a peores resultados de salud y tasas de retención en la atención entre estas poblaciones. Las estrategias culturalmente sensibles pueden ayudar a los proveedores a derribar las barreras sistémicas con el fin de aumentar la participación en la atención.
Este seminario web proporcionará a los proveedores una comprensión exhaustiva de la cultura latina, las barreras a las pruebas y el acceso a la atención que encuentran las personas latinas y las mejores prácticas para involucrar a esta comunidad en los servicios relacionados con el VIH.
Objetivos de aprendizaje:
Al finalizar esta sesión, usted podrá:
- Discutir la demografía latina/x y la composición de la población.
- Identificar los determinantes sociales de la salud y sus impactos en la comunidad latina al acceder a los servicios de VIH.
- Describir las mejores prácticas para crear y desarrollar nuevas iniciativas para llegar a la comunidad latina/x.
- Describir técnicas para involucrar a las mujeres y niñas latinas en el acceso a los servicios, las pruebas y la atención del VIH.
Nota: Créditos de educación continua no están disponibles para esta sesión.
Facultad: Yelitza Lemoine, CAN Community Health
This course is jointly provided by Postgraduate Institute for Medicine and HealthHIV.
Please review the content below at your own pace.
Release Date: September 28, 2023
Expiration Date: September 28, 2024
UAN: JA4008162-9999-23-328-L02-P
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Educational Objectives
After completing this activity, the participant should be better able to:
- Discuss the current state of HIV transmission and PrEP utilization among the Latino/x/a communities
- Identify different PrEP initiatives targeting the Latino/x/a community, including culturally sensitive education and outreach community-based testing programs and PrEP access programs.
- Evaluate the effectiveness of HIV PrEP initiatives for the Latino/x/a community, including their impact on HIV transmission rates, PrEP uptake, medication adherence, and health outcomes
- Develop strategies to improve and expand HIV PrEP initiatives for the Latino/x/a community, such as increasing funding for PrEP Programs, increasing access to PrEP medication, and addressing cultural barriers
Faculty
Yelitza Lemoine, CAN Community Health
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenter has nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
HIV remains a significant health issue for women, and multiple overlapping factors shape Black women's HIV-related risk. Pre-exposure prophylaxis (PrEP) offers critical advantages over other existing options, yet it remains significantly underused among Black women. This webinar will review the history of HIV prevention and Black women, strategies for engagement, and barriers to PrEP use for Black women.
UAN #: JA4008162-9999-23-339-L02-P
Start Date: 10/5/2023Expiration Date: 10/5/2024
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.Educational Objectives
After completing this activity, the participant should be better able to:
- Discuss the history of HIV prevention and Black women.
- Identify key strategies in engaging Black women in HIV prevention at each stage of the lifespan.
- Identify barriers to PrEP for Black women at each stage of the lifespan.
- Discuss the impact of culture and medical mistrust on healthcare decisions for Black women.
Faculty
Leisha McKinley-Beach, The Black Public Health Academy CEODisclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high-quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenter has nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been mitigated.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This course is jointly provided by Postgraduate Institute for Medicine and HealthHIV.
Please review the content below at your own pace.
Release Date: September 27, 2023
Expiration Date: September 27, 2024
UAN: JA4008162-9999-23-212-L02-P
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Educational Objectives
After completing this activity, the participant should be better able to:
- Discuss the current state of HIV transmission and PrEP utilization among the Latino/x/a communities
- Identify different PrEP initiatives targeting the Latino/x/a community, including culturally sensitive education and outreach community-based testing programs and PrEP access programs.
- Evaluate the effectiveness of HIV PrEP initiatives for the Latino/x/a community, including their impact on HIV transmission rates, PrEP uptake, medication adherence, and health outcomes
- Develop strategies to improve and expand HIV PrEP initiatives for the Latino/x/a community, such as increasing funding for PrEP Programs, increasing access to PrEP medication, and addressing cultural barriers
Faculty
Yelitza Lemoine, CAN Community Health
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenter has nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This session provides participants with an overview of HIV criminalization laws and data, along with strategies for combating HIV stigma and advocating for decriminalization.
Faculty: Kamaria Laffrey, co-managing director for HIV policy reform with The SERO Project and spokesperson for the treatment adherence and self-care campaign Positively Fearless
Learning Objectives:
At the conclusion of this session, you will be able to:
- Define HIV criminalization and identify the data that is most alarming.
- Explain five reasons why criminalization is a problem.
- Describe the nuances of strategy vs. implementation in legislative success.
NOTE: This session does NOT offer continuing education credits.
**THIS COURSE NO LONGER OFFERS CE CREDITS**
This course is jointly provided by Postgraduate Institute for Medicine and HealthHIV.
Please review the content below at your own pace.
Release Date: June 15, 2023
Expiration Date: June 15, 2024
UAN: JA4008162-9999-23-235-L02-P
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Educational Objectives
After completing this activity, the participant should be better able to:
- Describe how youth are different from adults living with HIV.
- Summarize approaches to support youth-friendly HIV care services.
- Discuss developmental aspects of youth that are living with HIV/AIDS.
- Discuss challenges and/or barriers to treatment and medical adherence for youth living with HIV/AIDS.
Faculty
Keristen Mazyck - Medical Care Manager, Ryan White Wellness Center
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenter has nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This webinar will discuss how to promote equity, improve access, and increase retention in HIV prevention and care among BIPOC communities. The faculty will identify barriers and dispel myths relating to PrEP use in BIPOC communities in order to encourage patients' use of PrEP while emphasizing strategies for fostering a strong patient-provider relationship. Additionally, the faculty will describe innovative healthcare delivery methods and initiatives to improve patients’ knowledge of PrEP and to increase PrEP uptake.
Release Date: September 15, 2023
Expiration Date: September 15, 2024
UAN: JA4008162-9999-23-308-
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Learning Objectives
At the end of this webinar, you will be able to:
- Explain the importance of increasing PrEP utilization among BIPOC communities.
- Identify barriers and dispel myths that impede engagement and retention in PrEP use in BIPOC communities.
- Discuss the roles of cultural responsiveness, trauma-informed care, and other factors in strengthening the patient-provider relationship.
- Briefly summarize PrEP formulations, effectiveness, adherence, and appropriate indications for PrEP use in BIPOC communities.
- Review and explain initiatives and unique strategies to increase PrEP uptake and retention in care among BIPOC communities.
Faculty
Tyris D. Ford, DNP, NP-C, FNP-BC, AAHIVS and Dr. Immirne M. Ouwinga
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenter has nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This module is intended for public use.
Learning Objectives
- Identify common trends and issues impacting the treatment of individuals with stimulant use disorder
- Discuss the current and emerging evidence behind pharmacological treatment of stimulant use disorder
- Identify and discuss the efficacy of psychosocial interventions for use in treatment of stimulant use disorder
- Identify the most effective approaches to inform clinical practice in treatment of ongoing stimulant use disorders
Note:
Jointly provided by Postgraduate Institute for Medicine and HealthHIV
This course will discuss the importance and need for engagement with faith groups and organizations specifically within the Latino/a/x community. There will be an exploration of the existing Latino/a/x focused faith groups and organizations in the Maryland area. Various resources will be shared that will inform both the personal assessment process as well as the development of either personal or organizational Strategic Religious Engagement plans. At the conclusion of the training, participants will be armed with tools to effectively form collaborative relationships with diverse Latino/a/x faith groups and organizations in order to further their HIV prevention work.
This course is jointly provided by Postgraduate Institute for Medicine and HealthHIV.
Please review the content below at your own pace.
Release Date: September 29, 2023
Expiration Date: September 29, 2024
UAN: JA4008162-9999-23-336-L02-P
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Educational Objectives
After completing this activity, the participant should be better able to:
- Define Strategic Religious Engagement and other key terms inherent within diverse faith cultures
- List at least three prevalent faith groups within the Latinx community
- Discuss common challenges at the intersection of Faith and HIV
- List at least three resources for ongoing engagement capacity development
- Develop a Strategic Religious Engagement plan
Faculty
Amy Zamot
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenter has nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This module focuses on Ryan White program updates and what to expect from the program in the future. The module also discusses Ryan White programmatic expectations and fiscal (grant) expectations.
Faculty: Ebony Fortune, MPH
Original Presentation Date: 4/6/2022
Contact Information: HAHSTACBAFiscal@dc.gov
After completion of all five modules, please select to receive your final certificate.
Final Certificate and Toolkit
After you have completed all seven HIVPCP modules, select this module to receive a final certificate and confirm your HIVPCP™ certification.
Once you obtain your certificate, you can register for the national database and access your toolkit materials including an e-mail signature, social media assets, office posters, and palm cards.
Fiscal Health Institute, Part 1
Realizing the Ryan White HIV/AIDS Program Fiscal Monitoring Standards in Practice
Understanding the expectations regarding policies and procedures for the Ryan White HIV/AIDS Program (RWHAP) Fiscal Monitoring Standards is important to ensure compliance and programmatic success. This session will provide practical solutions for properly implementing the RWHAP Fiscal Monitoring Standards, including, a review of select standards and a discussion of how these can be actualized in practice through the use of policies and procedures.
SPEAKERS
Jana Collins, KADAP Income Reinvestment Program
Visit sync2021.org/credits for information on claiming and receiving CME/CE credits for this session.Fiscal Health Institute, Part 2
Identifying, Tracking, and Monitoring Ryan White Program Income to Enhance Patient Outcomes
Is your organization generating income from third party payors or the 340B pharmacy program and have a Ryan White HIV/AIDS Program? This session will provide an overview of the Ryan White HIV/AIDS Program (RWHAP) program income requirements; explain how to track and monitor program income; and explain how to effectively plan and budget program income for service expansion.
SPEAKERS
Jana Collins, KADAP Income Reinvestment Program
Visit sync2021.org/credits for information on claiming and receiving CME/CE credits for this session.Track Description: Track Learning Objectives: Learn the differences in integrated planning guidance, the importance of taking an integrated, syndemic approach to HIV, HCV and STIs in the local and statewide ETE projects and identify strategies to implement integrated planning practices into respective areas; Understand clinical and organizations adaptations made to improve patient centered care coordination - and the financial incentives and support influencing the strategies presented; Learn the regulatory requirements of the 340B program and strategies used to support organizational growth; Learn Ryan White HIV/AIDS Program requirements around program income, definitions, sources, uses, allowable/unallowable expenses; and Review methods to budget Ryan White HIV/AIDS Program income. Session #1: Session Title: Planning to End the Epidemic Session Description: Session Learning Objectives: Describe at least two differences between the Guidances for Integrated Plan 1.0 and 2.0 Identify at least one best practice for developing the Integrated HIV Prevention and Care Plan Describe at least one resource to help support the integrated planning efforts for the development of the Integrated 2.0 Plan Learn organizing strategies and best practices to ensure a diverse array of voices and community members are represented in the integrated planning processes Participants will learn the importance of taking an integrated, syndemic approach to HIV, HCV, and STIs in local and statewide end the epidemics projects through the review of state-specific, community-driven case study Participants will learn successes and challenges of an effective EHE initiative Session #2: Session Title: Organization Sustainability Models Session Description: Session Learning Objectives: Develop an understanding of the shift that happens when moving from HIV treatment to HIV prevention. Evaluate the opportunities to diversify funding streams to create sustainable program services that can empower marginalized communities. Recognize the accounting nuances that come with diverse funding streams. Session #3: Session Title: Maximizing Your 340B Program: Balancing Optimization and Compliance Session Description: Session Learning Objectives: Review 340B Program Fundamentals, the basic compliance elements of an effective 340B Program. Share strategies to leverage on existing tangible and intangible organizational assets to grow its fiscal base through the 340B Program. Create a fiscal organizational risk assessment tool as it related to the 340B Drug Discount Program. Review examples of allowable costs, program expansion ideas, resources for program compliance, and 340B program best practices Session #4: Session Title: Expanding Your Services and Community Impact: Spending Program Income Session Description: Session Learning Objectives: Identify the Ryan White HIV/AIDS Program (RWHAP) program income requirements Definitions Sources Uses Allowable/Unallowable Expenses Review methods to budget program income
SYNChronicity 2020’s Fiscal Health and Health Systems track will cover a range of subjects. This track has been curated to build on best practices in the fiscal and organizational sustainability of healthcare and social service organizations by building their fiscal and grants management capacities, as well as building a systems thinking approach and external knowledge of syncing epidemics. Track attendees will begin by taking a look at integrated planning to end the epidemic. Attendees will then have the opportunity to review organizational sustainability models and examples of innovation in models of care within the field. Thursday’s sessions will consist of demystifying 340b compliance, and providing a breakdown of and best practices in Ryan White HIV/AIDS Program income tracking and allocation.
As jurisdictions look to develop their Integrated 2.0 Plans for calendar years 2022-2026, the lessons learned and best practices developed during the first integrated planning process can inform and guide the planning process for developing the Integrated 2.0 Plans. This session will provide an overview of the Integrated 2.0 Plan Guidance, including changes from the 1.0 Guidance and implications for the planning process. Presenters will also introduce best practices, resources, and tips for the integrated planning process and development of the integrated plans as well as present opportunities to leverage integrated plans and Ending the HIV Epidemic Plan development. This session will also review California’s innovative, community-driven EHE initiative. Informed by community members and accomplished through collaboration across key state departments, this initiative called for HIV, HCV and STIs to be treated as a syndemic, while also addressing social determinants of health and access to quality prevention and care services.
The alignment of U=U, Treatment as Prevention, rapid HIV testing, and access to PrEP can serve as a paradigm shift for organizations that have previously focused energy on HIV diagnosis and treatment alone. We can transform ourselves from HIV treaters to HIV preventers by engaging and empowering priority populations under a broader umbrella of care. This session will discuss how we can open the umbrella to include primary and specialty care for people with substance use disorders, seeking hormone therapy for gender affirmation, seeking STI testing and/or PrEP. This paradigm allows for synergies between programs and augments funding streams.
The 340B program is a federal program established in 1992 that allows safety-net health care organizations serving vulnerable populations to buy outpatient prescription drugs at a discount. This session will demystify the complicated regulatory requirements of the 340B program while also offering strategies for organizational growth. During this session, participants will learn how to maximize the use of 340B program income and best practices for maintaining compliance within the program. Through the expansion of services and enhancement practices, organizations can see beneficial outcomes for the clients you serve, and build sustainable operational policies and procedures.
This presentation will review the Ryan White HIV/AIDS Program Requirements around program income. The presentation will review the legislative and programmatic requirements around the definitions, sources, and allowable uses of program income. The presentation will review methods of budgeting program income and integrating program income into addressing client needs and barriers to accessing comprehensive HIV medical services. This presentation will include innovative ways to use program income to expand the reach and services offered by Ryan White HIV/AIDS program funded agencies.
Identify Allowable ways to spending program income
Session #1: Session Title: The Resilience Models of Long Term Survivors: Aging & HIV Session Description: Session Learning Objectives: Discuss the importance of Doctor/Patient relationship Understand the impacts of survivor’s guilt and Post Traumatic Stress Disorder on LTS Discuss therapeutic models that can be used to increase resilience for LTS Describe client-centered care that emphasized function in daily activities and quality of life Identify at least three critical challenges faced by aging Black MSM Describe strategies to integrate lived experiences of HIV stigma and the use of spirituality for Black men aging with HIV Understand HIV associated neurocognitive impairments that impact LTS Session #2: Session Title: Empowering Youth Leadership Through Cross Cutting Generational Concepts Session Description: Session Learning Objectives: Describe how undergraduate peer health educators can be used to implement culturally intervention programs on college campuses Discuss the process of developing culturally appropriate HIV/STI and substance use awareness social media material Identify barriers to creating inter-generational training teams for HIV/STI prevention List benefits for teens and older adults in working together collaboratively Session #3: Session Title: Sexual Health Frameworks Across Generations Session Description: Session Learning Objectives: Describe ways to validate the sexual experience of older adults in sexual health conversations Understand knowledge disparities of sexual health in Black and Latino youth in NYS
Hearing the medical and emotional journey of Long Term Survivors is key to developing models and strategies that work. There are biopsychosocial effects of thriving with HIV, Avoidance behaviors from practitioners, depression, substance use, weak social support structure impact the outcome of functional status and quality of care. There is a dire need to better understand and address the experience of Black MSM as they age. The socio-cultural constructs and intersections of HIV stigma, aging and spirituality are compounded by race. We have clinical models that drive higher stand and quality of care that directly impact health outcomes for LTS. Some Models include Mindfulness-based Stress Reduction, Patient centric healthcare service delivery model and Anderson’s Behavioral Model. There are still gaps in service that have been in adequately addressed such as obstacles in adherence, social support, harm reduction and clinical efficacy of social determinants of health.
STI rates among youth aged 14-21 on the Eastern Shore of Maryland are among the highest rates in the state of Maryland. The KISS (Keeping it Sexually Safe II) a peer led HIV/STI and substance use awareness and prevention program is being used on college campuses to address the burden of HIV in this community. The model of using inter-generational training teams to present HIV/STI prevention educational program in high school settings is a concept that has community talking. A shared understanding across generational lines about healthy sexual relationships and decision making skills could decrease HIV/STI rates.
Older LGBT adults are often overlooked when it comes to candid conversations around sexual wellness and HIV/STI prevention. This interactive series of presentations will explore techniques of talking about HIV/STI prevention to generations who have “heard it all before,” and learn how to validate the experiences of an older adult. SAGE’s Super Sex Workshops are designed to facilitate conversations between panel of professionals and LGBT older adult participants. The National Black Leadership Commission champions the promotion of health and reduction of disparities for black youth across New York State. With the increasing rates of chlamydia, gonorrhea, and syphilis among high risk youth of color aged 12-24 the utilization of “Real Talk” adult co-facilitated programs are part of this framework.
Discuss lessons learned and policy implications for comprehensive sex education programs
This series centers on writing, acquiring, and managing foundational and corporate grants as well as partnering with state entities and fundraising. This training covers grant readiness, collaboration and sustainability, preparation and presentation of needs statements, stewardship, and the role of budgets in grant applications.
This training’s production occurred through the Alive! Maryland program. The original sessions were conducted via the Zoom platform, and featured a question and answer section throughout the training.
Faculty: Laurie Jarrett Rogers, independent grant writer
Learning Objectives:
● Define and summarize what it means to be grant ready
● State the need for collaboration and sustainability
● Discuss how to prepare and present a community needs statement
● Demonstrate steps to develop a sound and tailored proposal to funding sources at the corporate, non-profit, and government levels
● Describe a plan on how to prepare and present a report to a potential funder
● Recognize the critical role of stewardship
● Explain the role of budgets in a grant application
NOTE: This module does NOT award credits.
| |
|
This module identifies and discusses relevant harm reduction techniques for people who use opioids, including people who use injectable drugs. The module will address how to hold patient-centered clinical conversations, incorporating harm reduction techniques. These strategies are then applied to a case study.
Learning Objectives
- Define Harm Reduction
- Identify factors that impact patient-provider relationships
- Describe Harm Reduction techniques for patient-centered clinical conversations
- Identify specific Harm Reduction strategies for patients who use opioids
- Apply Harm Reduction strategies to a case scenario
Harm Reduction 2023 Conference – Enduring Archives
Social Justice/Language Justice – 1.0 credit
National Perspectives on Harm Reduction and Community Health – 0.75 credit
Harnessing the Fury: Overcoming Barriers, Unveiling Pathways and Minimizing Harm – 0.5 credit
Drug User Health in a Syndemic Environment – 1.0 credit
October 25, 2023 to October 24, 2024
Jointly provided by Partners for Advancing Clinical Education (PACE) and HealthHIV
Estimated time to complete all modules: 3.25 hours
Target Audience
This activity is intended for Physicians, PAs, Pharmacists, Nurses, APRNs, Psychologists, Social Workers, Dentists and other healthcare providers who care for patients with substance use disorders or an infectious diseases(s).
Educational Objectives
Upon completion of this activity, participants should be able to:
Social Justice/Language Justice
-
Describe the impact of language and barriers to accessing services
-
Identify best practices for integrating language justice into service provisions
-
Describe the current environment of community relations
-
Describe best practices for engaging the community regarding drug user health
National Perspectives on Harm Reduction and Community Health
-
Explain the national harm reduction efforts and initiatives contribution to promoting community health
-
Describe harm reduction’s role in addressing public health challenges at the national level, such as substance use disorders and infectious diseases
-
Identify practical strategies and best practices in harm reduction that individuals and communities can implement to reduce harm, improve access to healthcare, and build stronger communities
-
Describe gaps in services needed to address the overdose crisis
-
Discuss harm reduction as a strategic model for addressing the overdose crisis
Harnessing the Fury: Overcoming Barriers, Unveiling Pathways and Minimizing Harm
-
Recognize the political impact on harm reduction and the current environment
-
Recognize harm reduction as a national public health issue
-
Identify priorities and effective advocacy strategies for harm reduction policies nationally
-
Describe successful models and lessons learned from harm reduction initiatives in Washington DC
-
Identify successful models and lessons from harm reduction initiatives in Washington DC
Drug User Health in a Syndemic Environment
-
Describe impact of living in a syndemic environment on overall quality of life
-
Describe best practices for advocating for clients to address whole person health
Faculty and Disclosure of Conflict of Interest
PACE requires planners, faculty, and others who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following financial relationships or relationships to products or devices they have with ineligible companies:
Ken Pettigrew Director of Capacity Building HealthHIV has no relevant financial relationship(s) with ineligible companies to disclose
Leo Sheridan Capacity Building Manager has no relevant financial relationship(s) with ineligible companies to disclose
Mark Robinson Regional Syringe Service Program Manager Family and Medical Counseling Service, Inc. has no relevant financial relationship(s) with ineligible companies to disclose
Ashley Elliott, MD Clinical Psychologist & Mental Health Consultant Vivid Innovations Consulting has no relevant financial relationship(s) with ineligible companies to disclose
Sonia Canzater, JD, MPH Associate Director, Infectious Diseases Initiative O’Neill Institute for National and Global Health Law, Georgetown University Law Center has no relevant financial relationship(s) with ineligible companies to disclose
Brian Corry Public Health Advisor Division of Overdose Prevention has no relevant financial relationship(s) with ineligible companies to disclose
Jenna Bluestein Advisor, Office of Public Health and the Office of National Drug Control Policy (ONDCP) has no relevant financial relationship(s) with ineligible companies to disclose
William McColl Founder and Owner McColl Strategies, LLC has no relevant financial relationship(s) with ineligible companies to disclose
Irene Kuo, PhD, MPH Associate Research Professor George Washington University Milken Institute School of Public Health Has no relevant financial relationship(s) with ineligible companies to disclose
George S. Kerr III, MT-CDSMP/DM Founder/CEO G III Associates has no relevant financial relationship(s) with ineligible companies to disclose
Leslie Demus Unity Healthcare has no relevant financial relationship(s) with ineligible companies to disclose
The PACE planners and others have no relevant financial relationship(s) to disclose with ineligible companies. The HealthHIV planners and others have no relevant financial relationship(s) to disclose with ineligible companies.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and HealthHIV. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
PACE designates this enduring material for a maximum of 3.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 3.25 contact hours.
Pharmacy Continuing Education
PACE designates this continuing education activity for 3.25 contact hour(s) (0.325 CEUs) of the Accreditation Council for Pharmacy Education. Type of Activity: Knowledge
Physician Assistant Continuing Education
PACE has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria.
This activity is designated for 3.25 AAPA Category 1 CME credits. Approval is valid until August 28, 2024. PAs should only claim credit commensurate with the extent of their participation.
Psychologist Continuing Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation
This program offers 3.25 continuing education credits for psychologists.
Social Work Continuing Education
As a Jointly Accredited Organization, Partners for Advancing Clinical Education is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 3.25 clinical, cultural competency or general* continuing education credits.
*Social Justice/Language Justice – cultural competency
National Perspectives on Harm Reduction and Community Health – general
Harnessing the Fury: Overcoming Barriers, Unveiling Pathways and Minimizing Harm – general
Drug User Health in a Syndemic
Environment – clinical
Dentist Continuing Education
PACE is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
PACE designates this activity for 3.25 continuing education credits.
Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.This course is jointly provided by Postgraduate Institute for Medicine and HealthHIV.
Completion of the following six (6) eLearning Presentations is necessary to qualify for accreditation:
- District/National Perspectives on Harm Reduction
- Interconnected Realities of Race, Gender, Class, and Harm Reduction in Substance Wellness
- Panel Discussion - Harm Reduction and the Trans Experience
- ADAP and Harm Reduction in Concert for Health Equity
- Clinical Safety Nets: Prevention, Treatment, & Care Linkage in Harm Reduction
- Streetwise Narratives and Narcan Training Workshop
Please review the content below at your own pace.
Release Date: May 6, 2024
Expiration Date: May 6, 2025
UAN: JA4008162-9999-24-119-H01-
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of clients with OUD/StUd and/or HIV.
Educational Objectives
After completing this activity, the participant should be better able to:
- Describe local and national harm reduction strategies.
- Identify inclusive strategies to effectively address diverse and intersectional needs within harm reduction initiatives.
- Promote comprehensive healthcare approaches for harm reduction to transform interventions aimed at reducing stigma.
Faculty
- Kenan Zamore, Senior Research Epidemiologist, DC Health
- Dr. Andrea M. Lopez, Associate Professor Dept of Anthropology, Univ. of Maryland
- Tyree Williams, Co-Executive Director, Brothers Obtaining and Navigating Dynamic
- Solidarity (BONDS)
- Kaniya Walker, Lead Linkage To Care Navigator at Heart To Hand, Inc.
- Taylor L Chandler, CEO TLC Consulting
- Dane Ray LGPC, CEO D & A Consulting Services
- Misty Carney, B.S., PharmD., AAHIVP Center Chief, Maryland Dept of Health
- Erin Russell, MPH, Principal, Health Management Associates
- George Kerr III, Founder and CEO of G III Associates
- Anthony Green, Executive Director Caged Bird Productions
- Abdur-Rahim Briggs, CEO Project Briggs
- Dr. Ami Angell, Director of Outreach, The h3 Project
- Kevin Fields PhD, Executive Director Father Factor
- Kenya Hutton, President Capital Ballroom Council
- Dr. O. Jermaine Bego, Senior Pastor CenterPoint Baptist Church
- Sierra Barnedo, Street Outreach Manager, SMYAL
- Tobie Smith, MD, MPH, Executive Director Street Health DC
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenter has nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 4 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 4 contact hour(s) (0. 4 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 4 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 4 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 4 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Track Description: Identify best practices in harm reduction advocacy used in response to COVID Discuss the influence of racism, stigma, criminalization in creating barriers to care Identify practical strategies for implementing trauma-informed de-escalation Discuss the legacy and principles of queer activism, the spectrums of gender, and the importance of intersectional frameworks in building solidarity Session #1: Session Title: Harm Reduction: Balancing Flexibility and Advocacy Session Description: Session Learning Objectives: Identify 3 techniques HR agencies used from the beginning of COVID, the origins of those ideas, and functioning w/o much guidance Understand where advocacy from HR programs affected changes in inflexible policies - such as Rx laws around buprenorphine and methadone Facilitate a discussion through which the group will identify 3 limitations HR programs have not adapt Identify key characteristics to anticipate in a 2nd wave and develop tactics HR can use to plan for each characteristic Session #2: Session Title: Barriers to Care: Racism and Stigma Session Description: Session Learning Objectives: Increase understanding of the impact of racism and stigma as a barrier by providing context through examples from COVID-19 restrictions/realities Increase understanding of criminalization by reviewing connections between current uprisings and the War on Drugs Highlight HR programs that have taken a stance to actively unpack this work and discuss tactics to promote and increase awareness of these activities Session #3: Session Title: De-escalation Session Description: Session Learning Objectives: Increase ability to recognize socio-cultural factors relating to conflict (Privilege, adherence, location) Review practical de-escalation skills Review tactics for integrating a trauma-informed lens to de-escalation Identify examples that diagnose the current political climate as an escalated state Session #4: Session Title: Lighthouse Learning Collective: Queering Narratives on Harm Reduction Session Description: Session Learning Objectives: Review the legacy of queer activism and its ties to drug use, the war on drugs, and criminalization Be introduced to the spectrums of gender, discuss the importance of intersectional frameworks in building solidarity, and review specific strategies to do so Answer the question, “What does it mean when your care is non-essential?” by reviewing COVID-19 response examples that have continued criminalization of the LGBTQIA community
The Harm Reduction Coalition and SYNChronicity 2020 are proud to unveil the new Harm Reduction track. Harm reduction is a set of practical strategies aimed at reducing the negative consequences around drug use; it is person-centered, non-judgmental and addresses drug use in the context of a person’s life. Attendees will have the opportunity to engage with experts in the field during the following presentations: Harm Reduction: Balancing Flexibility and Advocacy; Barriers to Care: Racism and Stigma; De-escalation: A Community Skill; and Queering Narratives on Harm Reduction.
Track Learning Objectives:
Harm Reduction Organizations like syringe exchanges are practiced in flexibility and advocacy as they navigate the needs of people who use drugs. Having a deep understanding of how the system has failed these groups allows harm reductionists to deftly navigate how to work through and outside of these systems. When the government finally acknowledged COVID-19, harm reductionists were able to quickly put together mutual aid resources, advocate for needed policy shifts, and develop creative ways to access those who were isolated and needed services. Hear from HRC staff and HepConnect grantees on some of the adaptations that were made, how they got to them, and how they plan to move forward in the post-COVID era.
As the paradigm shifts to finally recognize racism over race as a barrier to care, it is important to build connections between stigma and racism. The current uprisings against police brutality and the disproportionately spread burden of COVID-19 are not unrelated phenomena. Understanding how we criminalize both people and their behaviors, helps us understand any epidemic as a predictable consequence of our current infrastructure. Using the war on drugs as an example, we will explore how racism and stigma were systematized and built into the systems of our society.
As we begin to reckon with histories of violence and shift focus to small, community-based methods of transforming harm and addressing conflict as it arises, it is important to develop skills in de-escalation. Being able to manage conflict while prioritizing safety requires a dynamic understanding of power, privilege, and the environment. This workshop will discuss basic de-escalation skills with a trauma-informed lens as well as discuss why disengaging from the carceral state is so important to harm reduction and the safety of our program participants.
As the face of harm reduction becomes whiter and more centered on opioids, it is important to take a step back and understand how the LGBTQIA movement is tied to this. We will begin to unpack how the criminalization of people who use drugs, and those in the queer and trans community are not just parallel stories, but ones that are coincident. Many of the leaders at Stonewall were people who used drugs - and understanding that legacy helps to build networks of solidarity. This workshop will also begin to unpack how the idea of the binary not only obstructs our understanding of gender but of the carceral state, of substance use, and harm reduction. We will also look briefly look at how the COVID-19 response has continued the criminalization of this community.
| ||
| ||
Track Description:
The SYNC 2020 (virtual) HCV Health Track focuses on sharing stories, strategies, and successes to improve health outcomes from organizations serving people living with or at risk for hepatitis C. The track will highlight models and lessons learned for engaging underserved or socially-disadvantaged populations in HCV screening and treatment, integrating HCV and HIV services, and addressing federal and local policy, surveillance, and workforce barriers to HCV prevention, care and treatment.
Track Learning Objectives:
Discuss barriers facing access and engagement in HCV screening, care and treatment for populations most impacted by HCV.
Review innovative strategies that your organization could implement to improve engagement of vulnerable and socially-disadvantaged populations in HCV screening and treatment through telehealth, service integration, enhanced partnerships, and peer-to-peer support.
Identify structural barriers impacting access and engagement in HCV screening and treatment and the potential state and local advocacy opportunities that you can engage in.
Session #1:
Session Title: Realizing the Cure: HCV Testing and Treatment Models for Key Populations
Session Description:
This HCV Health session will highlight unique models that aim to connect key populations most-impacted by HCV to HCV testing and treatment and improve HCV-related health outcomes. The panelists will review strategies and lessons learned in implementing telehealth models of care for vulnerable groups, shared medical appointments for veterans, and co-location of substance abuse treatment and primary care.
Session Learning Objectives:
Discuss the importance of tailored approaches to HCV testing and treatment for key populations, such as veterans, people who inject drugs (PWID), and homeless.
Review real-world strategies to better engage and retain HCV patients who face barriers to care and treatment.
Describe adaptations, practical implementation, and tools to support uptake of strategies that reduce barriers to HCV care and improve health outcomes.
Session #2:
Session Title: SYNCing Services to End the Epidemics: Lessons Learned From Integrated HIV, HCV and Behavioral Health Initiatives in the Southern U.S.
Session Description:
This HCV Health session will highlight local and state initiatives that demonstrate effectiveness of HIV and HCV screening and care integration to enhance health outcomes for people co-infected with HIV and HCV. The panelists will review rationale, key strategies, and lessons learned from integrated service delivery in the southern U.S.
Session Learning Objectives:
Understand rationale, opportunities and challenges to integrating HIV and HCV testing programs and co-locating HIV and HCV services.
Identify strategies to use HIV/HCV testing integration to increase the effectiveness of each program.
Discuss challenges and successes associated with implementing evidence-based programs for HIV and HCV integration in “real world” care settings focusing on underserved, high risk populations.
Session #3:
Session Title: Optimizing HCV Screening, Linkage to Care, and Treatment for Currently and Formerly Incarcerated Patients
Session Description:
This HCV Health session will highlight three initiatives/projects that aim to enhance access and engagement in HCV screening, linkage to care, and treatment for individuals who are currently or formerly incarcerated. The panelists will review barriers, strategies, and lessons learned to improve the overall health outcomes of HCV patients in-facility and upon community reentry.
Session Learning Objectives:
Identify barriers to accessing HCV care and treatment during the time of re-entry into society.
Explore strategies and interventions to mitigate barriers and improve HCV treatment access for this vulnerable population.
Review lessons learned and practical strategies from three different initiatives for linking and retaining HCV patients who are incarcerated or recently released.
Discuss the impact of peer mentoring, support, and coaching resources on health outcomes of HCV patients in-facility and upon community reentry.
Session #4:
Session Title: Policy, Programs, and Payers: Addressing Structural Barriers to Improve HCV Health Outcomes
Session Description:
This HCV Health session will focus on structural barriers – including federal, state and local policies, surveillance, and workforce limitations – that impact HCV prevention, care and treatment. The panelists will review federal and state policies that impact minority communities with HCV, strategies to enhance access to syringe services, utilization of local surveillance data to track HCV in healthcare facilities, and resources for training of clinical and non-clinical providers in HCV.
Session Learning Objectives:
Describe disparate burden of HCV mortality among minority communities in the U.S. and policies impacting both HCV surveillance and equitable access to HCV care
Examples of innovative strategies employed by programs across the U.S. to improve access to sterile injection equipment and other harm reduction efforts in order to improve PWID health.
Review available training resources for clinical and non-clinical providers to increase capacity to treat patients with HCV.
This course is jointly provided by Postgraduate Institute for Medicine (PIM) and HealthHIV.
Please review the content below at your own pace.
NOTE: If you seek continuing education credits (CEUs) from PIM after completing the module, you will go to their website and complete a post-course check and an evaluation. If you will not seek credits, you will not need to take a post-course check, but please complete the non-credit evaluation at the end of the module. Whether or not you seek credits, you do not need to take a pre-course check and can go straight to the presentation.
Release Date: September 5, 2023
Expiration Date: September 5, 2024
UAN: JA4008162-9999-23-297-
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Educational Objectives
After completing this activity, the participant should be better able to:
- Identify the ways in which culture influences one’s health.
- Discuss how components of culture affect HIV.
- Assess the impact of health literacy on health outcomes.
- Incorporate 10 principles for building a culture of health in your current practice.
Faculty
Dr. Tamara A. Henry
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenter has nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This presentation discusses the best ways to affirm transgender and nonbinary persons. It explores ways for medical and support staff to affirm the identity and support the transition of their patients. The presentation includes a discussion on harm reduction best practices.
Faculty: Debb Dunn PA-C, MBA and Rhonda Carr
Learning Objectives:
- Identify key terms specific to transgender community members that affirm healthy sexuality
- Outline strategies for affirming transgender clients
- Identify barriers that limit the quality of services specific to transgender community members
- Outline effective strategies for affirming transgender community members' identity and transition support services to optimize customer satisfaction in transgender community members
- Outline harm reduction practices and strategies specific to the needs of the transgender community members
NOTE: This module does NOT award credits.
This presentation covers the myths and facts about HIV and AIDS in Washington, DC and serves as an introduction to those new to the topic.
Please review the content below at your own pace.
**This course is no longer offering CE credits.**
Among persons living with HIV in the United States, an estimated 15 to 30% have HCV coinfection. For persons living with HIV who have HCV coinfection, liver-related morbidity and mortality is a prominent non-AIDS-related complication—up to 80 to 90% of liver-related deaths in persons living with HIV are attributable to HCV infection-and proper treatment remains a priority. This webinar will discuss HIV/HCV co-infection in DC, particularly among people who inject drugs, and evidence-based prevention and treatment strategies.
This course is jointly provided by Postgraduate Institute for Medicine and HealthHIV.
Please review the content below at your own pace.
Release Date: October 12, 2023
Expiration Date: October 12, 2024
UAN: JA4008162-9999-23-344-
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Educational Objectives
After completing this activity, the participant should be better able to:
-
Discuss the epidemiology of HIV and HCV infections in populations of people who use drugs, in the District of Columbia.
- Outline established and emerging strategies to prevent infection in these individuals.
- Evaluate the approach to treatment of HIV and HCV in these individuals.
Faculty
Mark Sulkowski MD, Johns Hopkins University
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenter has nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
The Latino/a/x community is made up of diverse populations who often experience barriers to accessing equitable HIV care and services. This leads to poorer health outcomes and rates of retention in care among these populations. Culturally-responsive strategies can help providers break down systemic barriers in order to increase engagement in care.
This webinar will equip providers with a comprehensive understanding of Latino/a/x culture, the barriers to testing and access to care that Latino/a/x people encounter, and best practices for engaging this community in HIV services.
Learning Objectives:
At the conclusion of this session, you will be able to:
- Discuss the Latino/a/x demographic and the composition of the population.
- Identify the social determinants of health and their impacts on the Latino/a/x community when accessing HIV services.
- Describe best practices to create and develop new initiatives to reach the Latino/a/x community.
- Describe techniques to engage Latina women and girls in accessing HIV services, testing, and care.
NOTE: This session does NOT offer continuing education credits.
Faculty: Yelitza Lemoine, CAN Community Health
HIV Prevention Institute, Part 1
Impact of Policies on PrEP Access and Utilization
Given the current complexity of the United States healthcare system, implementation of health policies and strategies to mitigate barriers to HIV prevention are needed if we are to achieve our goals towards ending the HIV epidemic. The USPSTF Grade A recommendation and federal guidance requiring insurers to make PrEP and ancillary services available to individuals without cost-sharing is welcome news in efforts to expand access to PrEP. Our panelists will explore the impact the guidance from the USPSTF recommendations will have on access to PrEP, forthcoming long-acting options, and what barriers arise from utilization management techniques.
SPEAKERS
Scott Bertani, Director of Advocacy for HealthHIV
Mauda Monger, Chief Operating Officer at My Brother’s Keeper, Inc.
Carl Schmid, Executive Director, HIV+Hepatitis Policy Institute
Visit sync2021.org/credits for information on claiming and receiving CME/CE credits for this session.HIV Prevention Institute, Part 2
“How for Now:” Overcoming Barriers and Routinizing HIV Self-Testing
Adapting to an ever-changing pandemic landscape has both created barriers and sparked innovation in the field of HIV testing. Programs have been forced to adapt in order to meet clients where they are by effectively updating and changing services based on the frequent shifts in national, state, and local COVID-19 protocols. Providers are tasked with effectively communicating these changes to their patients and promoting strategies to keep them engaged in care. This session will cover the shift from in-person testing to self-testing models, exploring successes, barriers, innovation, and routinizing HIV testing in this time.Adapting to an ever-changing pandemic landscape has both created barriers and sparked innovation in the field of HIV testing. Programs have been forced to adapt in order to meet clients where they are by effectively updating and changing services based on the frequent shifts in national, state, and local COVID-19 protocols. Providers are tasked with effectively communicating these changes to their patients and promoting strategies to keep them engaged in care. This session will cover the shift from in-person testing to self-testing models, exploring successes, barriers, innovation, and routinizing HIV testing in this time.
SPEAKERS
Kate Curoe, Washington University in St. Louis CDC Capacity Building Assistance (CBA) Program
Carla A. Mena, Hands United at Latino Commission on AIDS
Nkechi Onyewuenyi, Patient educator at Legacy Community Health
Daniela P. Simba, Hands United
Javonte Williams, Philadelphia Department of Public Health
Kevin Lawson, Sr. US Marketing Manager for OraSure Technologies Inc.
Community Access National Network (CANN) will present its annual report on the state of HIV/HCV co-infection in the United States, including a summary of the HIV/HCV Co-Infection Watch, as well as the impact from COVID-19. The COVID-19 outbreak in the U.S. has exposed to many people, for the first, the inherent weaknesses that exist in our national healthcare system. From concerns about treatment coverage to widespread surveillance failures, this pandemic has demonstrated that, for most of the U.S., both federal and state governments have failed to invest in modernization, rural health, and surveillance infrastructure. This facilitated, multi-disciplinary panel discussion will focus on current data, real-world examples, and practical strategies for covering HCV cure therapies, federal and local harm reduction laws and policies, and the impact of COVID-19 on HIV and HCV transmission and services. Learning Objectives: Summarize key findings from the 5th Annual National Monitoring Report on HIV/HCV Co-Infection. Identify implications of the COVID-19 pandemic on HCV and harm reduction services, HCV treatment coverage and HCV treatment adherence. List specific considerations and impacts on rural health and rural providers serving people living with, or at risk for, HIV and/or HCV.
This training discusses the scope of LGBTQ2S+ young people’s life experiences of homelessness and mental health challenges by presenting stats and figures, such as how LGBTQ2S+ youth are significantly more likely to face homelessness due to structural discrimination, family rejection, and poverty.
Faculty: Dr. Rachel M. Schmitz
Contact Information: HAHSTACBAPrograms@dc.gov
Individuals living with HIV who are homeless or lack stable housing are more likely to delay HIV care and less likely to access care consistently or to adhere to their HIV treatment. Housing instability rarely happens without the additional challenges of mental health disorders, substance use, and economic and food insecurity, which can further complicate healthcare needs. This webinar will discuss the medical effects of homelessness and strategies to treat and retain people experiencing homelessness in HIV care.
Release Date: October 12, 2023
Expiration Date: October 12, 2024
UAN: JA4008162-9999-23-343-Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Educational Objectives
After completing this activity, the participant should be better able to:
- Describe the health impacts of homelessness for people with HIV.
- Identify barriers to care for people with HIV who are experiencing homelessness.
- Discuss interventions to promote engagement in HIV care for people experiencing homelessness.
Faculty
Sarah E. Rowan, MD Associate Director HIV and Viral Hepatitis Prevention | Public Health Institute at Denver Health
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty have nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Description: The Fair Housing Act prohibits discrimination in the sale, rental, and financing of dwellings and in other housing-related activities based on disability, among other protected classes. Generally, the Fair Housing Act applies to a broad range of persons and entities, including public housing agencies, property owners, landlords, housing managers, real estate agents, brokerage service agencies, and banks. This webinar will discuss Fair Housing Laws and Regulations as they apply to people living with disabilities and describe reasonable accommodations and modifications. This training will also identify resources available in the Washington D.C. area for people living with disabilities who are experiencing housing discrimination.
Faculty: Maria D. Moreno, PMP
Disclosure of Conflict of Interest: All relevant financial relationships for anyone with the ability to control the content of this educational activity have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Learning Objectives:
- Describe the history and the different laws that protect the fair housing rights of individuals and what classes are protected under the acts.
- Explain the different laws that protect the rights of individuals with disabilities, particularly persons living with HIV/AIDS.
- Describe the overall process of filing a complaint with a local fair housing agency.
- Identify fair housing resources and other housing programs that the United States Department of Housing and Urban Development (HUD) offers to individuals with HIV/AIDS.
Track Description: This track will highlight several projects and technical assistance funded by HRSA’s HIV/AIDS Bureau. Presentations will cover Special Projects of National Significance (SPNS), improving hepatitis C surveillance, training and technical assistance available to the HIV community as well as capacity building as it relates to Ending the HIV Epidemic. Track Learning Objectives: Describe projects within HRSA/HABs’ SPNS Initiative. Identify ways to diagnose and treat HIV/HCV co-infections using HCV surveillance List trainings and technical assistance offered by HRSA/HAB Identify Session #1: Session Title: HRSA Special Projects of National Significance (SPNS) Initiative Session Description: This session will address the topic areas of clinical and generational health. The presentation will describe the implementation and outcomes from a Health Resources and Services Administration (HRSA) Special Project of National Significance (SPNS) Initiative to use social media and digital technologies to improve engagement, retention in care, and outcomes along the HIV care continuum (e.g., medication adherence, viral suppression) for youth and young adults living with HIV. Ten demonstration sites across the country piloted their own unique, innovative, culturally congruent social media and digital technology interventions to improve HIV health outcomes. Session Learning Objectives: Describe how digital technology was used to improve HIV health outcomes for young people living with HIV Identify technology platforms that can be used in developing social media/digital technology HIV care interventions Describe the various HIV health outcomes addressed in the HRSA/SPNS initiative interventions. Share knowledge of barriers and challenges in using digital technology to improve HIV health outcomes of youth and young adults living with HIV. Session #2: Session Title: Improving Hepatitis C Virus Surveillance Capacity to Identify and Treat HIV/HCV Coinfection Session Description: This panel presentation will begin with an overview of the HHS Viral Hepatitis Strategy, presented by the Office of Infectious Disease and HIV/AIDS Policy (OIDP) followed by one of the participating states in the Hepatitis C Medicaid Affinity Group (lead by OIDP), who will provide an example of how they have developed and implemented state-identified strategies to treat and cure an increased number and percentage of individuals diagnosed with hepatitis C virus (HCV). The RAND Corporation will then present preliminary multisite evaluation results from a three-year project executed by Ryan White HIV/AIDS Program Part A and B recipients. Yale University will close out the panel by presenting their HCV data to care project, with an emphasis on generating a statewide HCV treatment cascade for coinfected persons. Session Learning Objectives: Describe the goals of the DHHS Viral Hepatitis Strategy. Discuss the need for improved Hepatitis C surveillance and use of data. Recognize data to care approaches that could be used in their jurisdiction. Session #3: Session Title: Training and Technical Assistance Available for Community Based Organizations and the HIV Community Session Description: Have you ever wondered what resources are available to your agency around new business models for Ryan White HIV/AIDS Program (RWHAP) community based organizations (CBO)? What leadership building opportunities are available for people living with HIV (PLWH) of color? Have you ever looked for a tool or TA resource to help enroll and engage PLWH in expanded health care coverage, or attempted to increase the health literacy of a RWHAP care and treatment provider for your clients? This workshop examines three projects funded by the Health Resources and Services Administration (HRSA), HIV/AIDS Bureau that offer training and TA opportunities for CBOs and the RWHAP community. The session will also highlight useful tools and materials currently available. This presentation will begin with an overview of the Center for Quality Improvement and Innovation (CQII) introduction to the new cooperative agreement to provide training and technical assistance (T/TA) to Ryan White HIV/AIDS Program (RWHAP) recipients and subrecipients to implement quality improvement methodologies. Presentation will include continued CQII offerings in T/TA such as quality academy, technical assistance calls, advanced training programs and quality award programs. In addition, CQII will discuss new offerings in T/TA such the quality collaborative and the quality improvement learning labs. Session Learning Objectives: Describe current resources available for T/TA available to RWHAP recipients and subrecipients to implement quality improvement activities. Describe the levels of T/TA available to RWHAP recipients and subrecipients to implement quality improvement activities. Describe new quality improvement activities for RWHAP recipients, subrecipients and people with HIV aimed at improving patient care, patient health outcomes and patient satisfaction. Session #4: Session Title: Building Community Capacity for Engagement to End the HIV Epidemic Session Description: This session will highlight key activities and strategies that support deeper community engagement activities related to leadership development of people with HIV as community leaders and key staff at agencies (e.g., community health workers, peer navigators, etc.). HRSA will share key themes from listening sessions with the Ending the HIV Epidemic listening sessions, key technical assistance and evaluation projects to support community engagement at the individual, organizational, and jurisdictional levels. Session Learning Objectives: Define key activities and strategies that support deeper community engagement activities related to leadership development of people with HIV. List key themes from listening sessions held with the Ending the HIV Epidemic jurisdictions. Present the key technical assistance and evaluation projects to support community engagement at the individual, organizational, and jurisdictional levels.
Course Description: Oral manifestations are the earliest indicators of HIV infection and can predict the progression of HIV/AIDS. Oral lesions occur in up to 50% of HIV-infected patients. Since oral lesions are considered the first clinical features of HIV infection, as well as highly predictive markers of immunosuppression, they can be useful for early testing, diagnosis, and treatment of HIV/AIDS patients. This self-paced module will discuss the various oral lesions that can occur in patients with HIV, treatment plans, and recommendations for follow up care.
Please review the content below at your own pace.
Release Date: November 14, 2023
Expiration Date: November 14, 2024
1 CEU available for CME, CNE, CPE, APA, AAPA, ASWB, and IPCE
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Educational Objectives
After completing this activity, the participant should be better able to:
Explain the different categories of oral lesions that may present in a patient living with HIV/AIDs.
Identify the signs and symptoms associated with oral lesions commonly diagnosed in patients living with HIV/AIDs.
Describe treatment options for the management of oral lesions and alleviating the related symptoms in patients living with HIV/AIDs.
Discuss the rationale for referring a patient to a dental professional for evaluation and biopsy of an oral lesion.
Faculty
Karyn Carr Porter, Public Health Registered Dental Hygienist-Chase Brexton
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty have nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Description
Join HealthHIV for a 75-minute live webinar featuring two experts who will discuss the unique challenges, opportunities, and strategies for outreach and engagement of people experiencing homelessness (PEH) in PrEP services. This is the second webinar in a two-part series “PrEP for People Experiencing Homelessness: From Outreach to Adherence” that aims to educate healthcare professionals on delivering equitable and individualized PrEP care to PEH.
Faculty:
Sarah E. Rowan, MD
Associate Professor of Medicine
University of Colorado, School of Medicine
Denver, CO
Lauren Banks, MFA, M.Div
Executive Director
National HIV/AIDS Housing Coalition
Washington, D.C.
Release Date: January 25, 2024
Expiration Date: January 25, 2025
UAN#: JA0007322-9999-24-015-H01-P
Target Audience
HIV care providers, primary care providers, pharmacists, nurses, nurse practitioners, physician associates, social workers, and other healthcare professionals in primary care, HIV care, and STD clinic settings involved in the care of patients living with and at risk for HIV.- Media: Enduring Material
- Release date: January 25, 2024
- Expiration date: January 25, 2025
- Time to Complete: 75 minutes
Educational Objectives
After participating in the activity, the learners are expected to be better able to:
- Identify structural barriers people experiencing homelessness (PEH) face to initiating and adhering to PrEP
- Summarize care models to reduce barriers to PrEP, such as mobile healthcare, street medicine, and pharmacy services
- Construct an interdisciplinary care team approach that includes partnerships with social support services to support PEH in PrEP care
Accreditation, Credit, and Support
1.25 credits/contact hours is available for completion of this on-demand activity for physicians, physician associates, nurses, social workers, and pharmacists.
In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc. and HealthHIV. Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This program has been supported by an independent educational grant from Gilead Sciences, Inc.
Physician Continuing Medical Education
Medical Learning Institute, Inc. (MLI) designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.Participation information will be shared through the ACCME's Program and Activity Reporting System (PARS).
ECMEC® Credit
The European Union of Medical Specialists-European Accreditation Council for Continuing Medical Education (UEMS-EACCME®) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 Credit(s)TM into European CME credit (ECMEC®) should contact the UEMS (www.uems.eu).Physician Associate Credit Designation Statement
Medical Learning Institute, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credits for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 CME credits. Approval is valid until January 25, 2025. PAs should only claim credit commensurate with the extent of their participation.Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded 1.25 contact hours and no pharmacology contact hours.Continuing Pharmacy Education
Medical Learning Institute, Inc. designates this continuing education activity for 1.25 contact hours (0.125 CEUs) of the Accreditation Council for Pharmacy Education. Type of Activity: Knowledge. UAN: JA0007322-9999-24-015-H01-PSocial Worker Continuing Education
As a Jointly Accredited Organization, Medical Learning Institute, Inc. (MLI) is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses are approved under this program. Regulatory boards have the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.25 general continuing education credits.
Interprofessional Continuing Education (IPCE) Statement
This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credits for learning and change.Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from Medical Learning Institute, Inc., the accredited provider, and HealthHIV, the joint provider, do not have any relevant financial relationships to disclose with ineligible companies.Disclosure & Conflict of Interest Policy
Medical Learning Institute, Inc. and HealthHIV are committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the CE activity.Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 70% or higher is needed to obtain credit. Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at beth@healthhiv.org.
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.
For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your Board Unique ID number, DOB (MM/DD), and a score of 70% or higher is needed to obtain MOC credit (75% is required for ABS).
For Pharmacists, MLI will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.
About This Activity
Medical Learning Institute, Inc. and HealthHIV are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of Medical Learning Institute, Inc. and HealthHIV.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute, Inc. or any of its partners, providers, and/or supporters
This module will explore strategies for optimizing your staff members' strengths through coaching and mentoring.
More than 60% of people who inject drugs (PWID) report having skin problems such as abscesses, ulcers, cellulitis, and other serious skin infections. Skin infection in PWID pose significant risks, including endocarditis, septicemia, and necrotizing fasciitis, which increases morbidity and healthcare costs for this population. To prevent the progression and spread of wounds in PWID, providers must be educated on the complications of drug use in this population and create a culture of trust to ensure this population seeks care.
Faculty: Barbara Pieper, PhD, RN, CWOCN, ACNS-BC, FAAN
Original Recording Date: 8/31/22
NOTE: This module does NOT award credits.Track Description: Identify solutions that make HIV care more accessible and that allow for a greater number of patients to be retained in care Identify how to forge partnerships and collaborations to decrease the fragmentation of community services made accessible to HIV positive patients Describe innovative data collection methodologies for program enhancement Determine how effective social marketing messaging can challenge social norms and HIV stigma Session #1: Linkage and Retention in Care for Health Outcomes Session Title: Equal and Equitable Care for Every Patient Through the Linkage to and Retention in Care Lens Session Description: Session Learning Objectives: Identify barriers to care and achievement of viral suppression Identify solutions that allow for wrap around services that make care accessible to clients in hard-to-reach areas Describe person-centered practices that increase client engagement and thus, linkage to care Understand the importance of health literacy in retaining patients in care Session #2: Partnerships and Integration Session Title: Forging Partnerships to End the Epidemic Session Description: Session Learning Objectives: Determine how to decrease fragmentation of care among the HIV positive reentry population through community service collaborations and provider trainings that aim to increase the delivery of culturally competent services Learn how to forge partnerships between hospital Emergency Departments and community providers to ensure that all HIV positive individuals have streamlined access to medical care Demonstrate the impact of collaborations among local ASOs, local health departments, and health systems on client health Define synergistic partnerships and identify how these partnerships make for the best practices for community engagement Session #3: Data Collection and Sharing Session Title: Data Collection for Program Enhancement Session Description: Session Learning Objectives: Identify key steps taken to initiate and maintain data to care within a large local health jurisdiction Empower leaders to rethink the role of the consumer as the “subject matter expert” within various care settings Learn a client satisfaction survey process that is less burdensome to the client and that measures different aspects of client satisfaction to provide results that will facilitate the adoption of appropriate QI activities Understand how to use existing staff and resources to form a multidisciplinary data collection team Session #4: Sexual Health Messaging Among MSM & Minorities Session Title: From Media Sexual Health Messaging to Treatment Session Description: Session Learning Objectives: Understand how investing in social marketing can change the conversation surrounding HIV and inform priority populations about local services Determine how effective social marketing messaging can challenge social norms and HIV stigma Learn how to integrate campaign materials to achieve organizational HIV communication goals
The Innovative Practice track features presentations from four programs that have implemented unique, leading-edge practices for HIV prevention and care across the continuum. Topics highlighted within these presentations include: bridging gaps that prevent HIV positive patients from being linked to medical care, utilizing synergistic partnerships to decrease the fragmentation of community services made accessible to HIV positive patients, utilizing data collection to enhance data collection methodologies, and effectively using media to reach and engage target populations in care.
Track Learning Objectives:
This session details solutions to overcoming universal barriers to care that prevent vulnerable populations from being linked to and retained in care. It also promotes reducing transmission rates at a population level through the expansion of medical care via support services, regular consistent patient-provider communication, and the formation of multidisciplinary treatment teams. Focusing on bridging the gaps that prevent HIV positive patients from being linked to medical care and retained in it, this session offers inventive solutions to the multitude of barriers that are encountered when doing so.
People living with HIV oftentimes have difficulty obtaining comprehensive care. This session depicts how collaborations among agencies can decrease the fragmentation of community services made accessible to HIV positive patients. These synergistic partnerships can help reduce the number of patients undiagnosed, decrease the number of patients who are diagnosed late, and ensure strong linkage to care. The integration of partnerships acts as a great avenue for keeping HIV positive patients retained in care by making a wide range of services easily available to patients at all stages of the continuum of care.
Effective data collection is of utmost importance in the advancement of all public health programs. This session details leading-edge practices in the realm of data collection. This session largely focuses on the importance of incorporating data collection metrics that aid in determining client satisfaction, specifically noting the importance of the use of focus groups and client satisfaction surveys when doing so. Also emphasized within this session, is the importance of creating multidisciplinary teams to develop, implement, and evaluate outcome measures focused on quality management. Overall, this session looks to propose innovative data collection methodologies for program enhancement.
Many Americans are not aware of PrEP or how effective antiretroviral medications are at improving the health of people living with HIV. This session details how strategically targeted and placed media can not only increase knowledge of HIV testing, PrEP, and treatment as prevention but also can connect people living with HIV to local HIV services. These efforts can ultimately decrease the stigma attached to receiving HIV treatment.
Please review the content below at your own pace.
Release Date: April 6, 2023
Educational Objectives:
- Identify the psychobiosocial/multiple meanings process model of addiction supporting integrative harm reduction therapy (IHRP).
- Describe harm reduction’s core principles.
- Explain an overview of IHRP’s seven therapeutic tasks.
**This course is no longer offering CE credits.**
Integrative Harm Reduction Psychotherapy consists of seven therapeutic tasks: managing the therapeutic alliance, the therapeutic relationship heals, enhancing self-management, assessment as treatment, embracing ambivalence, harm reduction goal setting and personalized planning for positive change. Specific techniques for achieving each task will be described including empathic listening and reflection create safety and alliance, Urge Surfing, Microanalysis, Unwrapping the Urge, dialoguing with both sides of the ambivalence, 18 Alternatives and the Optimal Use Plan.
Faculty: Andrew Tatarsky, PhD
Original Recording Date: 8/30/22
NOTE: This module does NOT award credits.A brief, introductory course to familiarize the learner with the purpose of this program and provide a brief overview of HealthHIV.
En este curso se examinará la importancia y la necesidad de colaborar con grupos y organizaciones religiosas, especialmente en el entorno de la comunidad hispana. Se explorarán los grupos y organizaciones religiosos existentes centrados en la comunidad hispana en el área de Washington. Se compartirán diversos recursos que servirán de base tanto para el proceso de evaluación personal como para el desarrollo de planes estratégicos de compromiso religioso personales u organizativos. Al final de la formación, los participantes dispondrán de las herramientas necesarias para establecer relaciones de colaboración efectivas con diversos grupos y organizaciones religiosas con el fin de promover su labor de prevención del VIH.
Objetivos de Aprendizaje:
Definir el compromiso religioso estratégico y otros términos clave inherentes a las diversas culturas de fe
Enumerar al menos tres grupos religiosos prevalecientes dentro de la comunidad latina
Discutir los desafíos comunes en la intersección de la fe y el VIH
Enumerar al menos tres recursos para el desarrollo continuo de la capacidad de participación
Desarrollar un plan estratégico de compromiso religioso
Facultad: Amalia Amy Zamot, HIV PCP Certified
Nota: Créditos de educación continua no están disponibles para esta sesión.
| |||||||
|
Track Description: Examine multiple obstacles to receiving healthcare in the LGBTQ+ community. Identify successful programs that have overcome obstacles to providing healthcare. Discuss the higher rates of smoking in the LGBTQ+ community and smoking cessation options. Determine peer based programs that lead to improving health outcomes. Session #1: Session Title: A bumpy ride: Navigating healthcare in the LGBTQ+ community. Session Description: Session Learning Objectives: Define barriers to care specific to the LGBTQ+ Community. Discuss the need for LGBTQ+ cultural competence in healthcare settings. Analyze the harmful effects of conversion therapy laws and other policies that harmfully affect healthcare in the LGBT community. Identify policies that will have an affirming effect on access to healthcare in the LGBTQ+ community. Session #2: Session Title: Following the Map: Working together to make change Session Description: Session Learning Objectives: Define methods to increase access to care in the LGBTQ+ community. Discuss successful campaigns to build healthcare capacity for LGBTQ+ healthcare providers. Learn how to collect and use data to enhance LGBTQ+ health equity. Become familiar with a case series of individuals who were denied necessary medical and mental health care while in ICE and/or CBP detention. Session #3: Session Title: Rolling down the window: Smoking Cessation in the LGBTQ+ community Session Description: This session will examine the higher rates of smoking in the LGBTQ+ communities and discuss cessation methods. Session Learning Objectives: Learn trauma-informed perspectives on nicotine and smoking cessation. Utilize tools for improving consumer health decisions. Session #4: Session Title: Enjoying the Ride: The importance of peer support and community in healthcare Session Description: This session will identify sex positive, gender affirming, peer led practices in LGBTQ+ healthcare and prevention. Session Learning Objectives: Examine best practices of community-based programs. Identify pregnancy options for transgender and gender nonconforming/non binary persons. Develop strategies to create peer support opportunities. Explain how heteronormative assumptions contribute to health disparities.
The LGBTQ+ Health track features four sessions that discuss barriers, policies, law, cultural competency, and successful campaigns regarding the LGBTQ+ community. This track will provide viewers with best practices and lessons learned from successful programs from across the country.
Track Learning Objectives:
This session will discuss barriers to healthcare in the LGBTQ+ community and ways of overcoming those barriers.
This session will give examples of successful statewide capacity building collaborations and the importance of data collection in the LGBTQ+ community
Welcome to Link 3 "Enhancing Culturally Appropriate Communication: Patient-Provider Interventions"!
This webinar describes the key factors that play a role when communicating with customers and patients, discusses the role of culture and health literacy, and looks at how stigma, discrimination, and bias can interfere with the implementation of equitable communication strategies.
**This course is no longer offering CE credits.**
For those certified in the past year, (between April 1, 2023 to March 26, 2024), please complete Module 7 to fulfill the updated knowledge gap requirement to maintain your HIVPCP™ certification. Upon completion of Module 7, please select this module to receive your extended certification.
Participants may earn up to 7.0 credits/ contact hours (CME, MOC, NCPD, CPE, AAPA, ASWB)
Mapping allows community members and organizations to plan better management of resources, develop and implement interventions and programs, and resolve resource conflicts.
This offering provides an overview of the Effi Barry Community Mapping Toolkit and how mapping social determinants of health can drive HIV prevention and intervention.
Faculty: Dr. Tamara Taggert, Kate Drezner, Stacey Cooper, and Anna Bacharach
NOTE: You do not need to complete a pre-course check or a post-course check to obtain your certificate of completion for this offering.
Mapping allows community members and organizations to plan better management of resources, develop and implement interventions and programs, and resolve resource conflicts. This webinar will delve into how mapping social determinants of health (SDOH) can drive HIV prevention and intervention. To illustrate this, the webinar will provide an overview of the Alive! Maryland 2023 Community Mapping Toolkit, "Visualizing Health Disparities to Advance Public Health."
Learning Objectives:
Describe how mapping toolkits can inform community members when responding to health, systemic, and societal needs.
Discuss mapping strategies for HIV surveillance in Maryland.
Explain the mapping process used to help identify and evaluate the strengths, assets, needs, and challenges of a specific community.
Identify mapping strategies to develop solutions and interventions addressing social inequities that impact HIV.
Faculty:
Jenea Lyles, Research and Evaluation Intern, HealthHIV, and second-year Master of Public Health student at The George Washington University Milken Institute School of Public Health
Molly Gribbin, MPH, Epidemiology Division Chief in the Center for HIV Surveillance, Epidemiology and Evaluation (CHSEE) at the Maryland Department of Health
NOTE: This module does NOT award credits.
In most settings, men are less engaged in healthcare services and have worse health outcomes than women. Strategies aimed at engaging men in healthcare have proven effective. This webinar will provide an overview of common health issues among men, how to engage and empower men to take control of their health, and strategies to overcome barriers to care for men.
This course is jointly provided by Postgraduate Institute for Medicine and HealthHIV.
Please review the content below at your own pace.
Release Date: July 20, 2023
Expiration Date: July 20, 2024
UAN#: A4008162-9999-23-277-L01-P
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Educational Objectives
After completing this activity, the participant should be better able to:
- Describe men's specific health conditions and basic health statistics.
- Identify strategies to improve early health screenings and disease prevention for men.
- Explain the importance of healthcare engagement and health screenings for men's health needs.
- Discuss strategies for empowering men to engage and advocate for themselves regarding their health priorities.
- Identify supportive services to overcome barriers, retain men in care, and optimize men's health outcomes.
Faculty
Tyris D. Ford, DNP, NP-C, FNP-BC TNJ Direct Primary Care, LLC
Jerry Washington, Heart to Hand
Lawerency Boone, DC Health
Corrie Franks, Family Medical and Counseling Services
Pablo Moulden, Nova Salud
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenter has nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This provides participants with core knowledge and skills needed to be effective as an ASO/CBO board member. The course reviews key roles and responsibilities of ASO/CBO board members, the basics of nonprofit board structure, composition and operations, and strategies for effective communication with internal staff of their organization.
Faculty:
Alan McCord
Reilly O'Neal
Melissa E Badowski, PharmD, MPH, FCCP, BCIDP, BCPS, FIDSA, AAHIVP
Elizabeth Moore, PhD, FNP-BC, ACRN
Leo Sheridan
Jenna Homsi
Guest Presenter: Charlie Romero - Consumer Engagement, PleasePrEPMe
Course Description
This course provides rationale on the importance of HIV prevention, sexual health coaching, and general PrEP navigation services.
Educational Objectives
Upon completion of this activity, participants should be able to:
- Describe a sexual health coaching model for engaging clients around PrEP.
- Identify two currently available PrEP modalities.
- Recognize additional methods that clients can use to prevent HIV transmission.
Faculty: Susan Hulse, PA-C, Physician Assistant, University of Rochester, Division of Infectious Disease
Description: HIV basics for Community Health Workers in Maryland.
Learning Objectives:
- Describe the current state of HIV
- Define basic information about HIV and the terminology used when talking about HIV
- Discuss HIV treatment options
- Describe prevention efforts
- Identify what can be done to educate and help populations most impacted by HIV
Module 1: HIV Prevention: Epidemiology, Interventions, and Public Health Strategies
Faculty: Jonathan Appelbaum, MD, FACP, AAHIVS
Course Description:
This course provides an overview on HIV in the U.S., touching on history, disparities, policies, and public health strategies, while emphasizing the importance of the HIV Prevention certification.
Educational ObjectivesUpon completion of this activity, participants will be better able to:
Describe the role of the HIV Prevention certification
Review current epidemiology of HIV in the United States
Describe disparities of HIV infection and access to prevention methods
Identify public health strategies and clinical interventions for HIV prevention
UAN#: JA0007322-9999-24-020-H01-P
Faculty: Steve Wood, BS, Senior Education and Advocacy Coordinator, HealthHIV
Description: This module will assist those interested in becoming a trainer of Community Health workers develop the necessary skills to facilitate meaningful sessions.
Learning Objectives:
- Develop effective presentation skills
- Recognize the importance of health literacy in the training process
- Develop effective time management processes
Faculty: Donna Sweet, MD, MACP, AAHIVS
Course Description
This course provides an overview of ARV therapies for optimal HIV treatment in primary care and HIV care settings.
Educational Objectives
Upon completion of this activity, participants should be able to:
Describe current HIV treatment guidelines and recent updates, including key considerations for optimal HIV treatment in primary care and HIV care settings.
Explain the process of early treatment start/rapid start protocols, outlining the steps involved and the rationale for initiating antiretroviral therapy promptly.
Identify recommendations on first-line and second-line antiretroviral regimens
Discuss laboratory studies to obtain at baseline and while monitoring response to therapy
Module 13 Objectives:
To describe and discuss:
- Best practices for utilizing the enrollment services available through the Maryland Health Connection and Regional Connector Entities
- Types of issues or problems that clients may encounter when applying for a qualified health plan or expanded Medicaid
NOTE: You must review ALL screens in this webinar in order to receive a completion and your certificate.
This course will teach participants basic strategies and skills to assess their existing board and identify and recruit new board members. This course also will help participants to identify opportunities for cultivating relationships with potential board members, as well as discuss key board member onboarding activities.
Faculty:
Alan McCord
Reilly O'Neal
Melissa E Badowski, PharmD, MPH, FCCP, BCIDP, BCPS, FIDSA, AAHIVP
Jenna Homsi
Guest Presenter: Megan Canon, MPH - Biomedical Intervention Coordinator, Colorado Department of Public Health and Environment
Course Description
This course provides an overview on the science behind PrEP and its effectiveness in preventing the transmission of HIV.
Educational Objectives
Upon completion of this activity, participants should be able to:
- Identify communities or individuals who are possible candidates for PrEP.
- Recognize PrEP disparities in various communities.
Module 2: HIV Testing, Assessing Risk, and Maintaining Serostatus Negative
Faculty: Jonathan Appelbaum, MD, FACP, AAHIVS
Course Description:
This course provides information on screening and diagnosing HIV, risk identification, short behavioral interventions, a status-neutral care approach for HIV services, and the importance of sexually transmitted infection screening and HIV treatment.
Educational ObjectivesUpon completion of this activity, participants will be better able to:
Explain the provision of HIV-related services through a status neutral care approach
Explain how to identify HIV risk
Identify appropriate short behavioral interventions
Describe screening for and diagnosing HIV infection
UAN#: JA0007322-9999-24-021-H01-P
Faculty: Steve Wood, BS, Senior Education and Advocacy Coordinator, HealthHIV
Description: This module will assist those interested in becoming a trainer of Community Health workers develop the necessary skills to facilitate meaningful sessions.
Learning Objectives:
- Define adult learning principles
- Learn best practices of adult learning principles
- Deliver instructional teaching that meets the specified learning objectives
Faculty: W. David Hardy, MD, AAHIVS
Course Description
This course provides considerations for managing common co-infections and opportunistic infections among PWH.
Educational Objectives
Upon completion of this activity, participants should be able to:
Identify effective strategies for managing common co-infections among people with HIV, including HCV/HBV, STIs, COVID-19, and Mpox
Develop comprehensive management approaches for common opportunistic infections among PWH
Faculty: Sara Engel, MS, CHES, Rochester Institute of Technology
Narrator: Steve Wood, BS, Senior Education and Advocacy Coordinator, HealthHIV
Description: STI basics for Community Health Workers in Maryland.
Learning Objectives:
- Describe the current state of STI (STD) infections
- Identify the reasons for rising rates of STIs
- Recognize patient risks and basic clinical facts associated with reportable STIs
- Describe how sexually transmitted infections are related to an increased risk of acquiring and transmitting HIV
This course explores how ASO/CBO board members can engage in strategic thinking to ensure their organization is implementing strategies that ensure organizational relevance and program sustainability.
Faculty:
Alan McCord
Reilly O'Neal
Melissa E Badowski, PharmD, MPH, FCCP, BCIDP, BCPS, FIDSA, AAHIVP
Jessica Arroyo
Leo Sheridan
Jenna Homsi
Course Description
This course provides strategies and best practices for delivering HIV PrEP navigation services.
Educational Objectives
Upon completion of this activity, participants should be able to:
- Describe what it means to practice cultural humility while navigating clients to PrEP.
- Identify ways to deliver client-centered services for people who seek PrEP
Faculty: Leo C. Sheridan, MLS, CCHW, Capacity Building Assistance Manager, HealthHIV
Description: Viral hepatitis A, B, and C basics for Community Health Workers in Maryland.
Learning Objectives:
- Recognize risks and basic clinical facts associated with strains of hepatitis A, B, & C
- Explain the function of the liver and how hepatitis impacts it
- Describe the effects and symptoms of hepatitis A, B, & C
- Recognize key terminology related to hepatitis A, B, & C
Module 3: Biomedical Strategies for Preventing HIV
Faculty: Brian Wood, MD
Course Description:
This course provides an outline for preventing HIV through PEP, PrEP, and TasP, covering clinical basics, research findings, CDC's guidance on PrEP, and emerging modalities.
Educational ObjectivesUpon completion of this activity, participants will be better able to:
Describe the clinical basics of prescribing PEP
Describe the clinical basics of prescribing PrEP
Discuss CDC’s guidance on oral and injectable PrEP
Faculty: Jonathan Appelbaum, MD, FACP, AAHIVS
Course Description
This course provides considerations for managing HIV care among older adults and long-term HIV survivors.
Educational Objectives
Upon completion of this activity, participants should be able to:
Identify common comorbidities most prevalent in older adults with HIV, based on findings from the REPRIEVE study
Discuss strategies and special considerations for managing HIV care in older adults who did not initiate early start on treatment
Evaluate the potential impact of long-term antiretroviral therapy on cardiometabolic risk and other comorbidities in older adults and long-term HIV survivors
Develop strategies for managing both antiretroviral therapy and cardiometabolic risk factors in patients with HIV
Faculty: Steve Wood, BS, Senior Education and Advocacy Coordinator, HealthHIV
Description: This module will assist those interested in becoming a trainer of Community Health workers develop the necessary skills to facilitate meaningful sessions.
Learning Objectives:
- Learn foundational methods for facilitating within instructional situations
- Develop effective moderation and facilitation skills
- Apply course facilitation skills to engage learners and transfer knowledge
Module 3 Objectives:
To describe and discuss:
- Case illustrations introducing MADAP eligibility guidelines and documentation requirements
NOTE: You must review ALL screens in this webinar in order to receive a completion and your certificate.
This course explores how board members can, and should, understand the finances of their ASO/CBO and make informed decisions regarding financial matters. The need for financial understanding is a critical part of being an effective board member. While board members do not need to be experts, all should all be familiar and comfortable with discussing finances, budgets, forecasting and other components of effective financial management.
Faculty:
Alan McCord
Reilly O'Neal
Melissa E Badowski, PharmD, MPH, FCCP, BCIDP, BCPS, FIDSA, AAHIVP
Jessica Arroyo
Jenna Homsi
Guest Presenter: Ashley Tolliver – Program Coordinator, Cook County Health
Course Description
This course provides client-engagement strategies for establishing trust and assessing client priorities and needs around HIV prevention.
Educational Objectives
Upon completion of this activity, participants should be able to:
- Identify engagement strategies that help establish trust with PrEP clients.
- List three assessment areas to assess a client’s priorities and needs around HIV prevention.
Faculty: Michelle S. Cespedes, MD, MS and Monica Gandhi, MD, MPH
Course Description
This course provides evidence-based HIV treatment optimization strategies for delivering quality HIV care among key populations.
Educational Objectives
Upon completion of this activity, participants should be able to:
Discuss innovative medicines and treatment optimization strategies, including the use of long-acting injectable antiretroviral therapy (LAI-ART) injectables
Identify model practices for treating pregnant persons and patients with competing priorities (e.g. unstably housed, people with substance use disorders)
Develop HIV treatment optimization strategies via street medicine models and status neutral clinic models
Describe adverse effects of ART, including weight gain and metabolic effects, and ways to address these issues
Module 4: Enhancing Cultural Humility and Understanding Barriers to Care
Faculty: Aniruddha Hazra, MD
Course Description:
This course provides a review of the HIV care continuum, impact of intersectional stigma on risk, cultural humility, trauma-informed care, and resources to mitigate financial barriers for clients.
Educational ObjectivesUpon completion of this activity, participants will be better able to:
Discuss the role of intersectional stigma, discrimination, trauma, and social determinants of health in HIV risk
Explain cultural humility, the role it plays in providing HIV care, and overcoming barriers to care
Describe trauma-informed care and its importance in HIV treatment and prevention
Introduce resources to mitigate financial barriers for clients
UAN#: JA0007322-9999-24-023-H01-P
Faculty: Erin Halligan-Avery, PhD, President & CEO, ConcernCenter
Description: Mental Health, bias, and values for Community Health Workers in Maryland.
Learning Objectives:
- Describe key mental health concerns for working with people experiencing adverse health diagnoses
- Recognize appropriate techniques to processing difficult news
- Utilize Mental Health First Aid techniques for harmful behavior
This course focuses on how ASO/CBO board members can best engage community and networks for resource development. Resource development is essential to ensure that program and financial bottom lines are stable so that organizations can achieve their mission effectively.
Faculty:
Alan McCord
Reilly O'Neal
Melissa E Badowski, PharmD, MPH, FCCP, BCIDP, BCPS, FIDSA, AAHIVP
Leo Sheridan
Jenna Homsi
Course Description
This course provides considerations for assessing medication and medical care costs, insurance coverage, and additional cost-covering options.
Educational Objectives
Upon completion of this activity, participants should be able to:
- Identify questions that help assess the financial and insurance status of PrEP clients.
- Identify sources that clients can use to cover their PrEP care costs.
Module 5: PrEP Adherence & Persistence
Faculty: Roger Bedimo, MD, MS, FACP
Course Description:
This course provides insight on vulnerable populations with PrEP disparities, impact of SDOH and barriers to PrEP, navigation models for access, and provider strategies for supporting adherence.
Educational ObjectivesUpon completion of this activity, participants will be better able to:
Describe the facilitators and challenges that impact PrEP uptake and adherence
Review strategies to support patient adherence and education
Describe considerations for starting, switching, and stopping PrEP
UAN#: JA0007322-9999-24-024-H01-P
Faculty:
Alan McCord
Reilly O'Neal
Melissa E Badowski, PharmD, MPH, FCCP, BCIDP, BCPS, FIDSA, AAHIVP
Elizabeth Moore, PhD, FNP-BC, ACRN
Jenna Homsi
Guest Presenter: Christopher Hurt, MD - University of North Carolina, Chapel Hill
Course Description
This course provides considerations for managing HIV care among older adults and long-term HIV survivors.
Educational Objectives
Upon completion of this activity, participants should be able to:
- Identify strategies for finding providers whothat can prescribe PrEP to clients.
- Identify routine screenings that clients can expect during their first PrEP care visit.
- Describe goals for clients to continue medical visits to use PrEP safely over time.
Module 6: Population-Based Considerations for PrEP
Faculty: Melissa Badowski, PharmD, MPH, FCCP, FIDSA, BCIDP, BCPS, AAHIVP
Course Description:
This course provides information on population-based considerations for PrEP, including the role of PrEP and TASP with family planning, health models to improve PrEP access, and combination HIV and STI treatment and prevention strategies.
Educational ObjectivesUpon completion of this activity, participants will be better able to:
Identify populations vulnerable to HIV infection who also experience disparities around PrEP
Review considerations for providing PrEP in populations with highest HIV incidence
Describe service delivery models that improve access to PrEP
UAN#: JA0007322-9999-24-025-H01-P
Faculty:
Alan McCord
Reilly O'Neal
Melissa E Badowski, PharmD, MPH, FCCP, BCIDP, BCPS, FIDSA, AAHIVP
Leo Sheridan
Jenna Homsi
Guest Presenter: Ken Almanza – Louisiana Department of Health, STD/HIV Program
Course Description
This course provides an overview on linkage to PrEP care such as how to find a PrEP-friendly provider and what your clients can expect from their first medical appointment to get PrEP.
Educational Objectives
Upon completion of this activity, participants should be able to:
- Identify possible side effects of taking PrEP and strategies to manage them.
- Recognize the lead-in dosing schedules for the different forms of PrEP.
- Identify strategies that clients can use to ensure they maintain adherence to PrEP.
Module 7: State of HIV Prevention and PrEP in 2024: Certification Maintenance for HIVPCPs
Faculty: Monica Gandhi, MD, MPH
Course Description:
This course provides an update on the current state of the HIV epidemic, key biomedical advances in HIV prevention, and evidence-based approaches to HIV prevention.
Educational ObjectivesUpon completion of this activity, participants will be better able to:
• Describe current HIV epidemiologic data and PrEP use-to-need data
• Identify considerations for implementing long-acting HIV prevention in clinical settings
• Review forthcoming biomedical advances in HIV and STI prevention
UAN#: JA0007322-9999-24-026-H01-PFaculty:
Alan McCord
Reilly O'Neal
Melissa E Badowski, PharmD, MPH, FCCP, BCIDP, BCPS, FIDSA, AAHIVP
Jenna Homsi
Course Description
This course provides strategies on self-care and fostering a healthy and supportive team culture at your program.
Educational Objectives
Upon completion of this activity, participants should be able to:
- Recognize symptoms of vicarious trauma and possible self-care activities that navigators can incorporate into their lives.
- Identify strategies that foster and promote a healthy work culture.
|
Please complete the course at your own pace.
**This course is no longer offering CE credits.**
Track Description: Session Title: Best Practices in Learning and Curriculum Development to Support Holistic Health Among MSM of Color Session Description: Black men who have sex with men (Black MSM) are among the highest risk groups for contracting HIV in the United States. Estimates indicate that nearly a quarter of Black MSM who are seronegative at age 18 will have HIV by the time they are age 25, and data from the CDC indicate that young Black MSM are almost four times more likely than their White or Hispanic peers to be HIV positive. This session provides health care workers and other stakeholders valuable skills in understanding how providers can overcome internal biases and link BMSM with HIV and those at high risk for HIV into testing, treatment, and care. This session will detail best practices to increase provider health literacy, enhance cultural mindfulness, increase collaboration amongst providers statewide, and develop and implement quality improvement projects as a multi-regional approach for improved health outcomes for Black MSM. It is essential for community-based organizations, federally-qualified health centers, and other organizations engaging Black MSM in any HIV prevention and treatment service. Participants will hear of a training that helps providers breakdown and overcome dominant, heternormative notions of Black masculinity, which often intersect with racism and violence, resulting in powerful stereotypes about men of color. Participants also will learn how that MSM of color described as “hard to reach” often are blocked by psychosocial and structural barriers determinants, such as racism, stigma, lack of cultural mindfulness, and other psychosocial barriers. Providers must address these barriers to effectively engage this population in services. Participants also will learn about a hands-on coaching and peer support program that addresses structural issues in HIV care and reduces HIV disparities experienced by Black MSM. Session Learning Objectives: Describe the social determinants that undermine the engagement, recruitment, and retention of Black MSM in health care; etail how social norms around masculinity support the creation and dissemination of stereotypes that make it hard for others to hear and understand the lived experiences and stories of individuals, including those of men of color, that do not align with the dominant story/culture of masculinity; Detail the strategies that were used to employ evidenced-based practices in healthcare settings; Outline diverse methods to engage and retain Black MSM in HIV prevention and treatment services; Discuss best practices to increase cultural mindfulness of service providers who work with Black MSM; Enumerate strategies to increase statewide (or multi-regional) collaboration among HIV service providers; and Explain how to develop and implement quality improvement projects to mitigate health disparities among Black MSM Session #2: Session Title: MSM of Color: Engagement and Community Collaboration Session Description: Black bisexual, gay, and men who sex with men (BGM) are less likely than their white counterparts to access and use biomedical interventions, such as pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) to reduce their lifetime risk of acquiring HIV. Organizations serving this population often describe BGM as a “hard to reach high risk population”. Session Learning Objectives: Describe the lived experiences and social determinants that undermine use of biomedical interventions and engagement in care among BGM; Discuss wellness and resilience among BGM from a sociocultural-reality framework; Describe the differences in overall wellness between BGM and other populations in the U.S.; Detail current beliefs held by providers concerning the reluctance of BGM to engage in health care services and biomedical HIV prevention approaches (PrEP and PEP), in particular; Discuss culturally-appropriate digital marketing approaches and how they can be used to recruit BGM into care and encourage use of PrEP and PEP; Leverage diverse qualitative and qualitative approaches to collect and analyze data in order to understand the population’s needs; and Detail how to create and sustain safe spaces for BGM that support retention in care and use of PrEP and PEP Session #3: Session Title: MSM of Color: Developing and Supporting Peer Navigation to Improve MSM Engagement and Retention in Care Session Description: Participants in this training will learn how the lived experiences and social determinants of Black men who have sex with men across can inform how they appraoch and are impacted by peer navigation. Speakers will discuss training elements essential to successful peer navigation training: HIV 101, HIV testing, social determinants of health, motivational interviewing, drug resistance and adherence to HIV treatment, entry into and retention in care, stigma, and implicit bias. Themes of holistic health, and their relationship to social network support and peer navigation, will be outlined. Session Learning Objectives: Explain the need for a peer navigation training programs, and how they are developed and implemented; Detail how a peer navigation training can help peers apply knowledge in their work with clients; connected peers to each other; and enable them to help clients move through the continuum of care more efficiently; and Describe the social determinants that inform BMSM’s uptake of health services and peer navigation support. Session #4: Session Title: MSM of Color: Expanding HIV Prevention and Care Opportunities Session Description: This session will discuss barriers to dissemination and uptake of preexposure prophylaxis (PrEP) undetectable=untransmittable (U=U) among men who have sex with men of color (MSMOC). To understand this issue, speakers will discuss cultural competency and its impact on the uptake of service delivery among medically LGBTQ+ populations. Engagement and retention of LGBTQ+ persons in care is vital to improving health outcomes among this among this population, while reducing HIV transmissions. Creating and delivering a curriculum that teaches cultural competency to providers services LGBTQ+ persons, however, has proven challenging. Members of the healthcare workforce are just as diverse as the communities they serve. They bring their own beliefs and biases about LGBTQ+ persons and how to engage them in care. To address this issue, the DC Health Department worked with HealthHIV to create a training for providers that address how to deliver culturally-competent services for individuals within the LGBTQ+ community. Participants attending this presentation will learn about the journey of creating this curriculum, from development to implementation. Session Learning Objectives: Discuss the cultural barriers and impact of social media and cultural norms impact impact uptake of HIV care and prevention services; Describe the health department’s role in ensuring providers have access to culturally appropriate training materials; and Detail the development and implementation of culturally appropriate materials within the health department along with community partners.
The MSM of color track addresses the intersections of HIV, HCV, STIs, and LGBT health among MSM of color, particularly among racial and ethnic minority groups in underserved and disenfranchised communities. Sessions in this track stress the importance of building the capacity of the healthcare workforce through multi-stakeholder informed learning and curriculum development; engagement and collaboration informed by quantitative and qualitative data; peer navigation programs based on community-based participatory action research-informed approaches; and stakeholder engagement supporting greater uptake in HIV prevention approaches among underserved perspectives.
Session #1:
In this session, participants will learn innovative approaches to engaging MSM across in HIV prevention, treatment, and support services through the recruitment, hiring, and training of appropriate team members; using data to drive HIV prevention practices; and engaging and retaining trained members of the client population in prevention, education, testing, treatment and social support services. We will also highlight how to create a network and base of engagement in areas where YMSM live, are educated and employed at a higher rate.
This module covers the various health and social needs of previously incarcerated individuals with substance use disorders upon returning home to their Washington, D.C. communities. It discusses the resources available to returning citizens, the challenges that these individuals may face, and some strategies providers can use to reduce these challenges. The module also reviews policy recommendations that can better support an individual’s transition from incarceration to reintegration in the community.
Learning Objectives
- Identify the physical health, mental health, and social needs of citizens returning to their Washington, D.C. communities following incarceration.
- Discuss the existing resources available to returning citizens in Washington, D.C.
- Assess common barriers faced by returning citizens that impede their successful reintegration into their communities.
- Consider policy changes that could remediate existing barriers and facilitate the successful transition back into the community.
This course is jointly provided by Postgraduate Institute for Medicine and HealthHIV.
Please review the content below at your own pace.
Release Date: September 26, 2023
Expiration Date: September 26, 2024
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Educational Objectives
After completing this activity, the participant should be better able to:
- Describe 3 indications for nPEP use
- Identify the key baseline and follow up clinical/laboratory assessments for nPEP
- Explain when and how to prescribe nPEP to PrEP
- Identify resources and guidelines for prescribing nPEP
Faculty
Chris Bositis, MD-Clinical Director for the National Clinician Consultation Center and Associate Professor of Family and Community Medicine at UCSF
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenter has nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This module provides insights on and discusses evidenced-based strategies to promote harm reduction among the youth population. Professionals gain an understanding and knowledge of the foundational principles central to harm reduction, in addition to substance-use trends among youth and strategies and tools to use when working with young adults.
Faculty: Keristen Mazyck, LISW-CP, HIVPCP
Learning Objectives:
At the end of this webinar, you will be able to:
- Identify foundational principles central to harm reduction.
- Describe harm reduction strategies tailored to youth.
- Discuss substance use trends among youth and adolescents.
- Discuss the prevalence of substance use among youth.
- Describe harm reduction issues specific to youth experiencing mental and/or behavioral health conditions.
NOTE: This module does NOT offer continuing education credits.
**This course is no longer offering CE credits.**
This module reviews the impact of diet and chronic illness on pain. It assists providers by improving their ability to discuss various evidence-based diets that can help to alleviate pain.Learning Objectives
- Discuss three dietary changes that will benefit pain patients
- Discuss two changes in physiology that enable dietary modifications to improve health and pain
- Counsel patients on preliminary dietary changes for pain
Welcome from Congresswoman Eleanor Holmes Norton
Congresswoman Eleanor Holmes Norton, now in her fifteenth term as the Congresswoman for the District of Columbia, is the Chair of the House Subcommittee on Highways and Transit. She serves on two committees: the Committee on Oversight and Reform and the Committee on Transportation and Infrastructure.
Before her congressional service, President Jimmy Carter appointed her to serve as the first woman to chair the U.S. Equal Employment Opportunity Commission. She came to Congress as a national figure who had been a civil rights and feminist leader, tenured professor of law, and board member at three Fortune 500 companies. Congresswoman Norton has been named one of the 100 most important American women in one survey and one of the most powerful women in Washington in another. The Congresswoman’s work for full congressional voting representation and for full democracy for the people of the District of Columbia continues her lifelong struggle for universal human and civil rights.
Keynote by Harold J. Phillips
Harold J. Phillips, MRP, Director of the White House Office of National AIDS Policy (ONAP). In this position, he leads the effort to set the Administration’s domestic HIV/AIDS priorities. This includes monitoring and implementing the National HIV/AIDS Strategy (NHAS), consulting with the Office of Management and Budget, coordinating with others on the Domestic Policy Council, the National Security Council, and the Office of the Global AIDS Coordinator to ensure America’s response to the HIV epidemic is accelerated, comprehensive and reflective of the lived experiences of those at risk of and living with HIV. This work is done to reduce the number of new HIV transmissions, improve the quality of life for people living with HIV and end the HIV epidemic.
Prior to joining the White House, Mr. Phillips served as the Chief Operating Officer for the Ending the HIV Epidemic Initiative in the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Health. There, he coordinated the initiative’s activities across the Department’s operating divisions.
SPEAKERS
Eleanor Holmes Norton, U.S. House of Representatives
Harold J. Phillips, Director, White House Office of National AIDS Policy
Visit sync2021.org/credits for information on claiming and receiving CME/CE credits for this session.U=U (undetectable equals untransmissible) refers to how individuals with HIV who have undetectable viral loads cannot transmit HIV. Join DC Engage, led by HealthHIV, on Tuesday, August 29, 2023 at 12:00pm Eastern for a webinar that will provide an in-depth exploration of the U=U concept, with a focus on its application to harm reduction.
The module reviews the challenges involved in achieving viral suppression and maintaining undetectable viral loads, particularly for people who use drugs. Providers also gain an understanding of potential opportunities for promoting activities that contribute to harm reduction strategies to reduce barriers and to increase drug user health.
Learning Objectives:
At the end of this webinar, you will be able to:
- Demonstrate enhanced knowledge of U=U (undetectable and untransmissible).
- Describe the limitations to achieving viral suppression and undetectable viral loads.
- Discuss the opportunities and best practices to promote activities that support viral suppression and undetectable viral loads.
Faculty: Patrick Ingram and Bobbi Gass, MPH
NOTE: This module does NOT offer continuing education credits.This module will provide a basic understanding of how to manage performance so you can reach your greatest potential as an organization.
This plenary session will address the intersection of the social determinants of health, the global COVID-19 pandemic, national HIV, HCV, STI, and LGBTQ healthcare planning efforts, and racial and social justice issues -- and the disparate impact on health equity and long-term health outcomes among medically underserved populations. Speakers from health departments, health centers, and AIDS service organizations (ASO) leaders will discuss their efforts to advance health equity through the development and implementation of culturally-responsive HIV, HCV, STI, LGBTQ, and now COVID-19 services. A panel discussion will sync these issues and intersections, as well as their collective impact on health outcomes at the individual and population levels, particularly among racial and ethnic minorities and LGBTQ persons. Learning Objectives: Discuss how health departments, health centers, and ASOs are leveraging innovative approaches to health care delivery to advance health equity across HIV, HCV, STI, and LGBTQ health; Describe how these efforts intersect with the social determinants of health and the current healthcare landscape, most notably the global COVID-19 pandemic and the national response to issues of racial and social justice; and Detail how these organizations have synced efforts across the local, state, and Federal levels to improve health outcomes at the individual and population levels, particularly among underserved racial/ethnic and LGBTQ populations.
This plenary will sync government agencies on Ending the HIV Epidemic (EHE) initiative during COVID-19. Ending the HIV Epidemic: A Plan for America (EHE) set an ambitious goal of harnessing the most powerful HIV prevention and treatment tools and leveraging advanced surveillance strategies to end the HIV epidemic in the United States by 2030. COVID-19 has complicated efforts as much of the public health workforce has been diverted to assist with the pandemic response. Hear from the lead EHE implementers, CDC, HRSA, BPHC, SAMHSA, HUD, and IHS as the leaders of the government health care agencies will discuss the latest updates on the Ending the HIV Epidemic implementation and how the community refocuses and re-engages in EHE midst of COVID-19. Federal leaders will discuss how their agencies are advancing the EHE initiative while responding to the COVID-19 pandemic. Learning Objectives: Discuss and sync activities and approaches of the federal agencies on Ending the HIV Epidemic implementation. Identify how COVID-19 has impacted Ending the HIV Epidemic implementation. Discuss how the federal agencies are leveraging responses to address COVID-19.
During this dynamic plenary, presenters will provide insights on the clinical, structural, and practical aspects of HIV prevention and care among aging populations. The clinical section will cover data and contextualize the needs of aging populations, prevention, and HIV care. The structural component will review health systems and best practices within care coordination for aging PWH. The practical component will provide patient advocate insights on aging, HIV, and comprehensive prevention for people over 50. Explain the implications of age on HIV disease progression Discuss how provider and consumer alignment impacts the care coordination of people aging with HIV Describe the structural factors that impact the provision of care for people aging with HIV Discuss the aging patient's perspective of HIV care coordination
Learning Objectives:
Identify HIV prevention and care services for people aging with HIV
Plenary 3: SYNCing on a National PrEP Program Through Community Advocacy and Innovation
Leveraging and aligning community involvement as a way to drive collaborative public health responses is vital to meaningfully address social determinants of health. And while today’s breakthroughs in several arenas have improved health care delivery and patient outcomes for many, we need community advocacy to capitalize on the science that sustains our health, including HIV prevention science. This session takes a critical look at innovative ways communities act as public health force-multipliers, through the creation of and advocacy for a National Pre-Exposure Prophylaxis (PrEP) Program that would increase equity and accessibility to this revolutionary HIV prevention tool.Plenary 3: SYNCing to End the Epidemics Through Transgender Health
This plenary session explores lessons learned, challenges and strategies for increased engagement within Transgender Communities to ensure retention in both treatment and prevention services.
SPEAKERS
Diana Oliva, Associate Director Community Engagement, Gilead Sciences
Mimi Shelton, Director of Trans Initiatives, Destination Tomorrow
Aryah Lester, Deputy Director, Transgender Strategy Center
Bamby Salcedo, President & Chief Executive Officer, Translatin@ Coalition
Zakia McKensey, Nationz Foundation
Plenary 4: SYNCing Resources and Action to Address the Socioeconomic Determinants of Syndemics and Epidemics
Research has long shown that epidemics and syndemics, including HIV, hepatitis C, sexually-transmitted infections, MPV, and COVID-19, disparately impact underserved, disenfranchised groups. These populations, which encompass racial and ethnic minorities, sexual and gender-diverse persons, substance users, and others, represent historically underserved populations. These groups often experience limited access to basic resources, including housing, food, housing, employment, and education, compounded by the stress associated with overlapping stigmas, such as racism, HIV stigma, and homophobia. Mitigating the impact of epidemics and syndemics requires a synchronized, syndemic approach that facilitates coordination, collaboration, investment, and innovation across local, state, and federal partners. Detailing the complex, intersectional social, political, and economic forces driving epidemics and syndemics in underserved communities is key to mitigating and ultimately eliminating them.
Speakers will describe how their agencies sync resources, including staff, funding, and knowledge, with Federal, state, and local stakeholders to address epidemics and syndemics – specifically those systemic and structural factors that undermine engagement, access, and use of clinical, behavioral, and support services. In addition, they will detail their current work to support and expand current evidence-based services and interventions that break down organizational silos and maximize impact on the social determinants of health.
The epidemics of HIV, sexually-transmitted diseases (STDs), hepatitis C (HCV), opioid misuse and overdose are widely recognized as a syndemic in the U.S. Access to health care services and medication-assisted treatment of opioid use disorders, income inequality, housing disparities, intensity of policing activities, employment status, and healthcare policies, are all related to the prevalence of substance misuse, overdoses, infection risk and morbidity. With the COVID-19 virus overwhelmingly targeting people who would already be vulnerable to disease, it is important to also examine how its interaction with other epidemics may exacerbate the disease burden in certain populations and increase health vulnerability. Panelists will highlight the importance of examining and addressing structural factors, health disparities and health equity to respond to the syndemic of HIV, HCV, opioids, and COVID-19 and how structural factors are addressed through intervention and policy to reduce vulnerability of at-risk areas and populations. List the HIV, hepatitis C (HCV), opioid misuse, and overdose epidemics as a syndemic, and examine the intersection of COVID-19. Identify how health disparities exacerbate syndemics in vulnerable areas and populations. Discuss strategies to address structural factors impacting vulnerable areas and populations in order to respond to the syndemics.
Learning Objectives:
Plenary 5: SYNCing Strategies for Improving Black Women’s Health
This session will begin by honoring three trail blazers in the HIV field. Their legacies have had a significant impact on Black women’s health and lives. Black women in the U.S. are disproportionately impacted by HIV and STIs. Identifying strategies that synchronize the state of HIV prevention with tools that engage and develop skills for communities and providers will positively impact Black women’s health.
Plenary 5: SYNCing to End the Epidemics Through Science
SYNCing to end the HIV, Viral Hepatitis, STI, Opioid, and COVID-19 epidemics through science starts with a recognition that the many of the same forces and inequities that drive one epidemic fuel the rest, and that scientific advancements in one field can lead to breakthroughs in another. During the height of the pandemic, advancements in COVID-19 vaccine research advanced at a stunning pace. These advancements were expedited, in part, by the groundwork laid by more than 30 years of HIV vaccine research.
This plenary will look at the latest in scientific advances in prevention and treatment research. Speakers will provide diverse perspectives on the state of the field today, including opportunities, obstacles ahead, and priorities for actions moving forward.
SPEAKERS
Myron Cohen, Director, Institute for Global Health and Infectious Diseases/HIV Prevention Trials Network
Lawrence Corey, Fred Hutchinson Center Cancer Institute / HIV Vaccine Trials Network
Wafaa El-Sadr, University Professor of Epidemiology and Medicine at Columbia University / HIV Prevention Trials Network
Gregorio Millett, Vice President and Director, Public Policy, AmFAR
Steven Shoptaw, University of California, Los Angeles
Visit sync2021.org/credits for information on claiming and receiving CME/CE credits for this session.Track Description: Track Learning Objectives: Identify examples of technological strategies used to enhance PrEP adherence monitoring and retention. Describe client-centered approaches for introducing PrEP and PEP in order to engage people in care. Examine strategies for incorporating priority populations in PrEP engagement. Discuss how to incorporate PrEP delivery into a variety of clinical settings. Session #1: Adherence & Retention Describe the model of a smart phone app for increasing PrEP uptake and adherence Identify strategies for measuring and improving PrEP adherence with biomarkers and virtual apps Explain the most recent developments in PrEP adherence monitoring and support tactics Session #2: Health Navigation and PrEP Session Title: Listening first: client-centered approaches to engaging clients in PEP assessments and PrEP monitoring Session Description: Session Learning Objectives: Identify model practices for increasing client engagement through client-centered approaches Describe best opportunities for PEP intervention Identify client-centered approaches to conducting HIV risk and PEP screenings Session #3: Scaling Within Priority Populations Session Title: Complicating the narrative: discussing strategies for engaging priority populations in PrEP uptake and use Session Description: Session Learning Objectives: Describe how to create an environment that is safe and nonthreatening for clients. Identify the various layers of domestic violence and its impact on health. Describe gender disparities in PrEP access and prescription in the United States Session #4: Health Systems and PrEP Session Title: Systems based and provider led approaches to increasing PrEP engagement in a variety of clinical settings Session Description: Participants will explore unique settings and avenues for PrEP engagement and delivery. They will discuss strategies for training staff about PrEP, implementing PrEP in an emergency department, and a social media campaign to increase PrEP engagement through “influencers”. Session Learning Objectives: Describe how to evaluate a social media campaign to increase PrEP engagement. Identify common barriers for providers around initiation and management of PrEP. Identify two strategies to increase provider comfort in managing PrEP. Explain how PrEP can be implemented in emergency department settings.
Participants will learn about system based and client-centered approaches to increasing engagement and retention in PrEP. Topics covered will include model strategies for promoting PrEP adherence using technology, the importance of PEP as a gateway into PrEP usage, the prioritization of overlooked populations in PrEP outreach, and the incorporation of PrEP awareness into different areas of clinical practice.
Session Title: Technology based strategies for improving PrEP adherence and promoting increased retention in care.
Session Description:
Participants will learn about tools to increase PrEP adherence and retention through virtual technologies and in-person practices.
Session Learning Objectives:
Participants will explore client-centered approaches to engaging clients in PEP assessments and ongoing PrEP use. The presentations include practical risk assessments for PEP initiation and model practices for increasing client interest and engagement in PrEP.
Participants will discuss strategies for engaging priority populations in PrEP uptake and ongoing use and explore the ways in which certain populations and their barriers have been left out of conversations about PrEP. The presentations focus on different priority populations, including people who have experienced intimate partner violence, gender and sexual minorities, and people experiencing financial instability.
Course Description:
This webinar provides an overview of different PrEP initiatives that have been proven effective in the Latino/a/x community. The faculty will also discuss practical strategies that increase the knowledge, comfort, and skills of providers to engage this community in PrEP services.
Faculty: Yelitza Lemoine
Learning Objectives:
Discuss the current state of HIV transmission and PrEP utilization among Latino/x/a Communities
Identify different HIV PrEP initiatives targeting the Latino/x/a community, including culturally sensitive education and outreach community-based testing programs and PrEP access programs.
Evaluate the effectiveness of HIV PrEP initiatives for the Latino/x/a community, including their impact on HIV transmission rates, PrEP uptake, medication adherence, and health outcomes
Develop strategies to improve and expand HIV PrEP initiatives for the Latino/x/a community, such as increasing funding for PrEP Programs, increasing access to PrEP medication, and addressing cultural barriers
This course is jointly provided by Postgraduate Institute for Medicine and HealthHIV.
Please review the content below at your own pace.
Release Date: September 25, 2023
Expiration Date: September 25, 2024
UAN: JA4008162-9999-23-324-L02-P
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Educational Objectives
After completing this activity, the participant should be better able to:
- Discuss the history of HIV prevention and women
- Identify key strategies in engaging women in HIV prevention at each stage of the lifespan.
- Identify barriers to PrEP for women at each stage of the lifespan
Faculty
Leisha McKinley-Beach, The Black Public Health Academy CEO
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenter has nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
**THIS COURSE IS NO LONGER OFFERING CE CREDTIS**
This course is jointly provided by Postgraduate Institute for Medicine and HealthHIV.
Please review the content below at your own pace.
Release Date: May 25, 2023
Expiration Date: May 25, 2024
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Educational Objectives
After completing this activity, the participant should be better able to:
- Discuss the epidemiology of HIV and HCV infections in populations of people who use drugs, particularly those who inject drugs.
- Outline established and emerging strategies to prevent infection in these individuals.
- Evaluate the approach to treatment of HIV and HCV in these individuals.
Faculty
Mark Sulkowski MD, Johns Hopkins University
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenter has nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This module discusses how to promote equity, improve access, and increase retention in care among Black, Indigenous, and People of Color (BIPOC) communities in healthcare. The faculty dispel barriers and myths relating to PrEP use in BIPOC communities to encourage patients’ use of PrEP while emphasizing the importance of a strong patient-provider relationship. Additionally, the faculty provide innovative healthcare delivery methods and initiatives to improve patients’ knowledge of PrEP and to increase PrEP uptake.
Start Date: 7/28/2023
Expiration Date: 7/28/2024
UAN #: JA4008162-9999-23-285-L02-P
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.Educational Objectives
After completing this activity, the participant should be better able to:
- Explain the importance of increasing PrEP utilization in BIPOC communities.
- Identify barriers and dispel myths that impede the engagement and retention of PrEP use in BIPOC communities.
- Describe how cultural humility, trauma-informed care, and other factors can strengthen the patient-provider relationship.
- Briefly summarize PrEP formulations, effectiveness, adherence, and appropriate indications for PrEP use for BIPOC patients.
- Describe innovative healthcare delivery methods to improve access to PrEP for BIPOC communities.
- Review and explain initiatives and unique strategies to increase PrEP uptake and retention in care among BIPOC patients.
Faculty
Dr. Immirne M. Ouwinga, MD and Dr. Tyris Ford, DNPDisclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high-quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenters have nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1 contact hour.Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 Clinical continuing education credits.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.This webinar will introduce the concept of harm reduction and its critical role in public health initiatives, especially those focused on HIV prevention and care. The faculty will discuss the evolution of HIV services and strategies for integrating innovative harm reduction approaches into these initiatives.
Learning Objectives:
Discuss the importance of harm reduction as a component of wider public health efforts.
Describe the types of public health initiatives where harm reduction activities can be integrated.
Recognize specific techniques that can be used to facilitate effective integration of harm reduction activities into public health initiatives.
Identify the healthcare access points—whether in the community or in a specific institution—in which these techniques can be utilized, and how they can be effectively integrated.
Faculty: George Kerr III, Founder and CEO, G III Associates, LLC
Release Date: May 7, 2024Note: Continuing education credits are not available for this webinar.
Taking a patient’s sexual history allows healthcare professionals to provide high-quality patient care by appropriately assessing and screening individuals for a broad range of sexual health concerns. A sexual history should be taken as part of routine health care, as well as when there are symptoms or physical exam findings suggestive of STIs. This self-paced learning module will address the 6 P’s of sexual history taking and strategies to ensure a comprehensive and inclusive approach for all patients.
Release Date: August 14, 2023
Expiration Date: August 14, 2024
UAN: JA4008162-9999-23-293-L02-PTarget Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Educational Objectives
After completing this activity, the participant should be better able to:
- Recall the 6Ps of a sexual history
- Identify opportunities to reduce barriers to sexual history taking
- Apply strategies to incorporate a sexual history into patient visits
Faculty
Diane Bruessow MPAS, PA-C, DFAAPA Yale School of Medicine
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty have nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
TThe maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0. 10 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Black women continue to be disproportionately affected by HIV and they experience poorer health outcomes and face barriers to accessing care if diagnosed with HIV. This session will discuss the impact of HIV on Black women and highlight the provision of biomedical strategies. The session will also include "real talk" and a discussion of innovative programs that can facilitate the end of HIV among Black women. Address challenges posed to the prevention of HIV among Black women Evaluate the need for PrEP uptake for Black women Discuss the best practices of HIV prevention programs designed for Black women
Learning Objectives:
This module will provide tips on how to recruit and hire so that your organization can thrive under the best people.
This presentation addresses how to prepare for an audit, the importance of annual financial statement audits and what to look for from the process.
Faculty: A. Michael Gellman, CPA, CGMA
Original Presentation Date: 11/5/2015
Contact Information: HAHSTACBAFiscal@dc.gov
This course is jointly provided by Postgraduate Institute for Medicine and HealthHIV.
Please review the content below at your own pace.
Release Date: October 17, 2023
Expiration Date: October 17, 2024
UAN: JA4008162-9999-23-348-
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Educational Objectives
After completing this activity, the participant should be better able to:
- Discuss the state of HIV testing in the United States.
- Identify barriers and challenges to HIV testing at the individual, structural, and policy level.
- Describe strategies to increase engagement in HIV testing.
Faculty
Tyris D. Ford, DNP, NP-C, FNP-BC, AAHIVS
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
Amanda D. Castel, MD, MPH, FAAP, AAHIVS: Grant/Research Support/Consultant & Advisory Board - Gilead
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Facilitators
Self Care Discussion with DC Engage Micro-Grantees
- Caged Birds
- Capital Ballroom Council
- Empowerment Enterprise II
- Far Southeast Family Strengthening Collaborative
- Father Factor, Inc.
- Harm Reduction at Westminster
- Innergy, Inc.
- Marshall Heights Community Development Organization
- Project Briggs
In this webinar, medical professionals will learn short behavioral interventions they can use before, during, and after providing clients' with test results, to make the process more comfortable and relatable. Short behavioral interventions are based in human psychology and are practical, consistent, and short term. By implementing these interventions into daily practice, the goal is that clients', including those from special populations, will have a better experience in your office and a greater likelihood of behavior change.
Learning Objectives:
Upon completion of this course, participants will be able to:
Discuss the role that human psychology plays in creating short behavioral interventions in medical practice.
List at least 3 practical things they can do to set the stage for conversations about test results.
Identify at least 3 practical things they can do to make the process of sharing test results more comfortable for the client.
Discuss how to adapt short behavioral interventions to special populations such as minors, sex workers, and people with different abilities.
Explain how personal bias may impact conversations about test results.
Note: This session does NOT offer continuing education credits.
Track Description: The Social Determinants of Health (SDOH) track features thirteen presentations addressing four SDOH elements: health equity, LGBTQ education, trauma, and mental health and housing. Social Determinants of Health are the conditions where people are born, live, work, and socialize that are shaped by resources, money, and power which promote health inequities and impact the overall health of individuals and communities. This track will explore SDOH within the context of these four elements and identify how organizations, public health programs, health departments, and providers can assess and respond in order to address client needs to impact overall health and wellness. Track Learning Objectives: Identify how to use data to guide the development of programs, provision of services, and allocation of resources to address Social Determinants of Health. Describe how to address Social Determinants of Health specific to LGBT communities. Explain the impact that trauma has on the Social Determinants of Health. Identify strategies to assess mental health and housing needs of patients/clients that impact overall health outcomes. Develop a plan to incorporate practical strategies to address Social Determinants of Health into practice. Session #1: Social Determinants of Health & Health Equity Session Title: Live, Work, Play, and Stay: Exploring Social Determinants of Health and the Impact on Health Equity Session Description: Session Learning Objectives: Identify how to access and apply data toward organizational efforts to engage clients and optimize partnerships. Assess the effect of Social Determinants on HIV transmission, as well as the impact on treatment and adherence. Identify strategies to measure Social Determinants of Health in your practice to monitor patient health, improve programs, and target resources more effectively. Determine how to incorporate stakeholder feedback into quality improvement plans to impact treatment cascades. Session #2: LGBTQ Education Around Social Determinants of Health Session Title: Exploring the Social Determinants of Health and LGBTQ Education Across the Lifespan Session Description: Session Learning Objectives: Identify how to implement best practices with organizations to provide education, research, and community engagement with regard to LGBTQ-focused care. Describe how to improve provider capacity with regard to sexual orientation and gender identity to improve HIV screening for patients. Identify community or school-based programs that positively impact LGBTQ-inclusive sexual health programming. Session #3: Trauma and Social Determinants of Health Session Title: The Impact of Trauma on Social Determinants of Health: Combating Discrimination Based on HIV-Status and Opioid Use Disorder Session Description: This session will examine how trauma impacts Social Determinants of Health and health outcomes. The first presentation will address the role of trauma and discrimination on risk behaviors, coping, and engagement for patients, as well as coping and engagement for providers. Marginalized individuals may experience trauma that we do not frequently thoroughly address, and there is often stigma and shame around trauma; providers can experience secondary trauma from the experiences of clients and patients as well. The second presentation will address how the American with Disabilities Act can be utilized to protect individuals with HIV and Opioid Use Disorder from discrimination based on either of those diagnoses. Session Learning Objectives: Describe how trauma and secondary trauma affects the patient-provider encounter. Define trans-generational trauma and how it affects Social Determinants of Health. Identify ways to incorporate tools into practice to assess patient/client trans-generational trauma. Determine how to identify illegal discrimination against persons with HIV, Opioid Use Disorder, and other disabilities in employment, housing, and the provision of public and private services. Identify access points for additional information about discrimination. Session #4: Mental Health, Housing, and Social Determinants of Health Session Title: Two Critical Components in Addressing Social Determinants of Health: Mental Health & Housing Session Description: Session Learning Objectives: Analyze the relationship between HIV, mental health, and substance use and the risk of HIV infection. Identify tools for assessing mental health disorders in patients with HIV. Identify strategies to assessing mental health and housing needs of patients/clients that impact overall health outcomes. Compare sociodemographic and HIV care outcome differences between clients with a reported mental health diagnosis to those clients without.
This session will provide the learner with guidance on how to address the Social Determinants of Health (SODH) which impact health equity through measurement, mapping, data collection and analysis, and evaluation. Presenters will also address incorporating practical strategies, and stakeholder engagement to create client/patient-centered services that reduce stigma and increase engagement.
This session will explore the importance of providing LGBTQ+ focused education and care to address Social Determinants of Health from youth through adulthood. Presentations will address challenges in providing LGBTQ-focused care particularly in a politically charged atmosphere, generalizable lessons learned, as well as how to build provider capacity for cultural responsiveness to improve health outcomes for patients. Furthermore, this session will share best practices with regard to LGBTQ inclusion in sexual health education for youth.
This session will address the two critical components of mental health and housing for addressing Social Determinants of Health. It is critical when addressing mental health issues with patients to also examine substance use and how this impacts vulnerability to HIV and other negative health outcomes. Stigma around mental health issues, HIV, and substance also can negatively impact engagement and retention in care, medication adherence, and overall health outcomes.
Facilitators:
Alfredo D. Smith, AIDS United (Social Justice)
Larry Bryant, The Reunion Project (Social Justice)
Scenario Discussion 1: Analyze methods used to decrease stigma by using terms that avoid negative associations to increase access to services while promoting a positive and affirming space.
Scenario Discussion 2: How can we educate and strengthen community responses to address drug user health, and promote retention in care? What has history taught us as it pertains to policies and access for the harm reduction community within hospital settings, and how do we continue to move forward?
Objectives
Identify challenges and best practices for reducing barriers to language
Describe experiences and preventive measures to improve community response
Note: This session does not offer continuing education credits.
Description:
During the 60-minute webinar, two experts will discuss the unique challenges, opportunities, and strategies for outreach and engagement of people experiencing homelessness (PEH) in PrEP services. The experts will share model practices, highlight patient case examples, and discuss strategies for engaging PEH in PrEP, such as PrEP medication adherence and persistence, adherence to medical appointments, and addressing common comorbidities.
Faculty:
Monica Gandhi MD, MPH
Director, UCSF-Bay Area CFAR
Professor, UCSF School of Medicine
San Francisco, CA
Patrick Ingram, MHSA
Community Health Specialist
PrEP Coordinator, The Red Door Clinic
Minneapolis, MN
Release Date: December 8, 2023
Expiration Date: December 8, 2024
UAN#: JA0007322-9999-23-119-H01-P
Target Audience
HIV care providers, primary care providers, nurse practitioners, physician associates, other clinicians, and other healthcare professionals in primary care, HIV care, and STD clinic settings involved in the care of patients living with and at risk for HIV.- Media: Enduring Material
- Release date: December 8, 2023
- Expiration date: December 8, 2024
- Time to Complete: 1 hour
Educational Objectives
After participating in the activity, the learners are expected to be better able to:
- Describe barriers people experiencing homelessness (PEH) face to initiating and adhering to PrEP and how providers and navigators can address these challenges.
- Identify culturally competent strategies and messaging for engaging PEH in PrEP.
- Summarize best practices for providing support to initiate PrEP, such as access to PrEP medication, labs and clinic visits for people experiencing homelessness (PEH).
- Identify collaborative strategies for interdisciplinary teams to guide PEH in their use of PrEP.
Accreditation, Credit, and Support
1.0 credit/contact hour is available for completion of this on-demand activity for physicians, physician associates, nurses, social workers, and pharmacists.
In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc. and HealthHIV. Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This program has been supported by an independent educational grant from Gilead Sciences, Inc.
Physician Continuing Medical Education
Medical Learning Institute, Inc. (MLI) designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.Participation information will be shared through the ACCME's Program and Activity Reporting System (PARS).
ECMEC® Credit
The European Union of Medical Specialists-European Accreditation Council for Continuing Medical Education (UEMS-EACCME®) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 Credit(s)TM into European CME credit (ECMEC®) should contact the UEMS (www.uems.eu).Physician Associate Credit Designation Statement
Medical Learning Institute, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1.0 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. Approval is valid until December 8, 2024. PAs should only claim credit commensurate with the extent of their participation.Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded 1.0 contact hour and no pharmacology contact hour.Continuing Pharmacy Education
Medical Learning Institute, Inc. designates this continuing education activity for 1.0 contact hour (0.10 CEU) of the Accreditation Council for Pharmacy Education. Type of Activity: Knowledge. UAN: JA0007322-9999-23-119-H01-PInterprofessional Continuing Education (IPCE) Statement
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.Social Worker Continuing Education
As a Jointly Accredited Organization, Medical Learning Institute, Inc. (MLI) is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses are approved under this program. Regulatory boards have the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.0 general continuing education credit.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from Medical Learning Institute, Inc., the accredited provider, and HealthHIV, the joint provider, do not have any relevant financial relationships to disclose with ineligible companies.Disclosure & Conflict of Interest Policy
Medical Learning Institute, Inc. and HealthHIV are committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the CE activity.Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 70% or higher is needed to obtain credit. Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at beth@healthhiv.org.
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.
For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your Board Unique ID number, DOB (MM/DD), and a score of 70% or higher is needed to obtain MOC credit (75% is required for ABS).
For Pharmacists, MLI will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.
About This Activity
Medical Learning Institute, Inc. and HealthHIV are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of Medical Learning Institute, Inc. and HealthHIV.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute, Inc. or any of its partners, providers, and/or supporters
Session Description: Session Learning Objectives: Discuss the colonization of America and the issues colonization has created in social service and healthcare fields Identify strategies for prioritizing Black and Brown client voices Describe how vulnerability and trauma arise when health department POC represent marginalized communities impacted by health inequities, while simultaneously doing the work to remediate disparities Understand the synergy between how structural systems of oppression drive POC staff and community related inequities, while providing solutions that empower participants to build meaningful relationships and work towards equitable public health practices Describe the need for primary care providers to receive comprehensive training in HIV prevention Discuss the role of stigma, discrimination, trauma, and social determinants of health in HIV prevention
This dynamic session will focus on how colonization has influenced the health/social service fields and the need to increase the capacity of emerging leaders of color within these spaces to equip them with skills, mentors, and introspection that help them advance in their varied personal career trajectories. This session will cover the development of HealthHIV’s HIV Prevention Certified Provider Program (HIV PCP), which is an online, self-paced CME curriculum composed of five courses in HIV prevention detailing the pertinent clinical and practice information that clinicians need to effectively employ HIV prevention interventions.
Session Description: During this session, participants will learn how stigma undermines access to care in marginalized communities, most notably racial and ethnic groups and sexual and gender minorities, which bear a disparate burden of non-communicable and infectious diseases, such as HIV, hepatitis, and COVID-19. Stigma in this session will be described as a set of interrelated oppressions based on clients’ race, sexual orientation, gender expression, and/or health status. Several persons with HIV will describe the impact of stigma in their lives. Providers, in turn, will discuss evidence-based approaches to improving access to care among underserved client populations. Participants will have an opportunity to submit questions before and after the session. Session Learning Objectives: Describe the multifaceted, interrelated oppressions and biases that inform how stigma is enacted and reinforced at multiple levels (interpersonal, community, and societal/political) and experienced by individuals; Discuss how stigma undermines access to care, especially within underserved and marginalized communities; and Detail how providers address their own implicit biases, while working with their organization and beyond to create safe, stigma-free spaces for clients.
Session Title: Syncing Activism, Advocacy & Organizing Through HIV Criminalization Modernization Session Description: This session will educate participants about HIV and the criminalization of people living with HIV that is occurring domestically and globally. Knowledge of this issue coupled with other stigmatizing intersectionalities are what participants need in creating and building advocacy programs. The model of this session will be based off a coalition recently organized and two established movements as your key presenters which are – The Ending HIV Criminalization and Overincarceration in Virginia Coalition (ECHO VA), Florida HIV Justice Coalition, and the Georgia HIV Justice Coalition. Session Learning Objectives: Describe the legal underpinnings of HIV criminalization across the United States. List at least three (3) lessons learned from the experiences of three (3) HIV Criminalization Modernization movements (Georgia HIV Justice Coalition, Florida HIV Justice Coalition, and Ending HIV Criminalization and Over Incarceration in Virginia Coalition). Assess available resources to support advocacy efforts around HIV Criminalization.
This course highlights the prevalence and causes of stimulant-based psychosis, describes how to care for a patient experiencing stimulant-based psychosis, and provides resources for individuals who experience this type of psychosis.
Learning Objectives
- Identify the epidemiology and presentation of stimulant induced psychosis
- Discuss the diagnosis, management, treatment, and treatment responses of acute amphetamine induced psychosis
- Identify best practices for ongoing care of chronic amphetamine psychosis
Please review the content at your own pace.
**This course is no longer offering CE credits.**
Learning Objectives:
- Identify common substances used by individuals in Washington DC
- Describe effective harm reduction strategies for individuals who use substances
- Differentiate between an individual being high/intoxicated and an overdose
- Describe model practices to help clients with substance use disorder navigate treatment and services
Session #1: Session Title: Developing Whole Person Health Systems to Support People Who Inject Drugs Session Description: Session Learning Objectives: Identify strategies for establishing a clinic designed to provide services to people who inject drugs (PWID) Discuss best practices for offering harm reduction services in rural areas Discuss integrating Hepatitis C navigation pathways in a substance use disorder treatment program Identify strategies for implementing low cost and easily accessible software to assess community needs, improve service delivery, and enhance data and reporting for harm reduction services Connect with other colleagues and groups working on safe consumption space organizing and advocacy in the United States Session Title: Utilizing Client-Focused Engagement to Increase Linkage to Care Session Description: Session Learning Objectives: Identify 3 benefits of patient advisory committees (PACs) Identify challenges to linking PWID to Hepatitis C treatment Discuss how to build relationships with people who use drugs Discuss strategies to engage PWUD/PWID through partnerships Identify tools designed for linking clients into HCV care and treatment Discuss the nationwide lack of access to culturally competent mental, substance use and behavioral health services for Latinx MSM Discuss the scope and challenges associated with crystal meth use in the Latinx MSM community Session #3: Session Title: Integrating Low-Barrier Substance Use and Harm Reduction Services Session Description: Session Learning Objectives: Discuss how to integrate SUD screening and MAT delivery in a primary care setting, and why this approach is essential in ramping up the response to the opioid crisis Identify how the Harm Reduction approach improves retention in care, decreases mortality, and allows for treatment of other health co-morbidities Identify the public health benefits of expanding access to MOUD for incarcerated populations and upon reentry Discuss the advantages of integrating and co-locating syringe service programming with services to treat OUD, including supporting mental and behavioral health, providing HCV testing and case management, and addressing other social determinants of health Examine what a client-centered approach means for people who inject and use drugs
People who inject drugs (PWID) face challenges in accessing whole-person health within the current health system landscape. This session will discuss how jurisdictions are implementing coordinated efforts to support PWID through syringe service programs (SSPs), Hepatitis C and STI testing, data-to-care models, and other support services. Additionally, this session will cover an update on safe consumption spaces and strategies to support this effort in the US.
Session #2:
Engaging with clients in the planning and delivery of healthcare services is a critical component for building relationships and achieving positive health outcomes. This session will discuss client engagement and cultural understanding as it relates to drug use, including utilizing community advisory boards, providing incentives, offering whole-person supportive programming, and promoting cultural awareness of clients.
Expanding access to substance use disorder treatment and support services is a priority for organizations serving PWID/PWUD. This session will cover the role of harm reduction, low-barrier support services, and HIV/HCV testing in comprehensive harm reduction programs. Presenters will discuss implementing routine HIV and HCV screening, integrating SUD screening in primary care, medication for opioid use disorder among reentry populations, and developing wraparound support services in syringe service programs.
This module will walk you through the process of effective success planning and knowledge transfer so you can enjoy long-term success.
This course is jointly provided by Postgraduate Institute for Medicine and HealthHIV.
Please review the content below at your own pace.
Release Date: July 20, 2023
Expiration Date: July 20, 2024
UAN: JA4008162-9999-22-361-L04-P
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Educational Objectives
At the end of this session, you will be able to:
- Define motivational interviewing (MI) as a counseling style.
- Identify the key concepts of MI.
- Describe the spirit of MI.
- Identify four principles of MI.
- Demonstrate the MI approach.
Faculty
Christopher Rogers, PhD
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenter has nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This module identifies the importance of sustainability, income diversification and examines the sources for particular organizations.
Faculty: Ingrid Floyd, M.B.A.
Original Presentation Date: 11/29/2012
Contact Information: HAHSTACBAPrograms@dc.gov
“Cured” Documentary — A Presentation by the Co-Directors
Described as “fascinating” (Hollywood Reporter), “riveting” (The Queer Review) and “astonishingly rich … one of the best documentaries of this or any year” (British Film Institute), CURED chronicles the battle waged by a small group of activists and their allies who declared war against a formidable institution — and won a crucial victory in the modern movement for LGBTQ equality.
Until 1973, the medical establishment classified every gay person — no matter how well-adjusted — as the victim of a disease. As long as lesbians and gay men were “sick,” progress toward equality was impossible. CURED takes viewers inside the David-versus-Goliath battle that led the American Psychiatric Association (APA) to remove homosexuality from its manual of mental illnesses.
Even though CURED highlights a story from the past, it offers lessons that are profoundly relevant today. This film reveals how a handful of determined individuals can create lasting social change. Watch the trailer for CURED at https://www.cureddocumentary.com.
The film will be broadcast on PBS as a part of the acclaimed documentary showcase, Independent Lens, on October 11th – National Coming Out Day. You can tune in at 10/9c (check local listings). CURED will also be available to stream for free on pbs.org and the PBS app for 30 days after the broadcast.
In this session, co-directors Bennett Singer and Patrick Sammon outline the groundbreaking discoveries they made during the production process for CURED and how this chapter of LGBTQ history relates to other social justice movements.
SPEAKERS
Patrick Sammon, Co-Director and Co-Producer of CURED
Bennett Singer, Co-Director and Co-Producer of CURED
Visit sync2021.org/credits for information on claiming and receiving CME/CE credits for this session.Impact of COVID-19 on ASOs, CBOs, and Service Providers
The course of the COVID-19 pandemic in the United States echoes that of HIV over the past four decades, with racial and ethnic groups and sexual and gender minorities bearing a disparate burden of both diseases. The pandemic has further exacerbated the psychosocial determinants that have created barriers to HIV prevention and health services for many people at risk and living with HIV. This session will review the results of the COVID-19 Rapid Risk and Resiliency Project (R3A), an exploratory sequential multiple methods study that sought to produce a deeper understanding of the lived experiences of HIV service providers (clinical and non-clinical) and customers of HIV prevention and care services in Washington, DC and Maryland.
The presentation will outline the facilitators, barriers, lessons learned and best practices. It will further engender a discussion about next steps in providing HIV prevention and care services during a pandemic, including support for rapid adoption of service delivery models; restoring access to services for customers of HIV prevention and care services; and introducing changes to strengthen systems capacity to prepare for future disruptions.
SPEAKERS
Circe Gray Le Compte, Senior Director of Health Services Research and Evaluation at HealthHIV
Erin Starzyk, Director of Health Services Research and Evaluation, HealthHIV
Gerran Thomas, Clinical Capacity Building Assistance Manager at HealthHIV
Visit sync2021.org/credits for information on claiming and receiving CME/CE credits for this session.- Teacher: Charlotte Kugler
Telehealth: Implementation During COVID-19 and Implications Moving Forward
Telehealth encompasses a broad range of healthcare activities, such as direct provision of health services by video or phone, use of apps or text message services to promote health, integration of remote monitoring or wearable devices to provide real-time health data measures, and tele-mentoring consultations. The uptake of telehealth has been slow in the United States for the delivery of healthcare services for individuals with chronic conditions like HIV and viral hepatitis. The COVID-19 pandemics offered providers and patients the opportunity to deliver and receive remote healthcare services via telehealth. This session will provide learners an overview of telehealth models used delivery of prevention, care, treatment, and support services for individual with chronic conditions, as well as, to forecast future use of technology in healthcare.
SPEAKERS
Michael Shankle, Senior Director of Capacity Building, HealthHIV
Visit sync2021.org/credits for information on claiming and receiving CME/CE credits for this session.
This webinar will explore the role of community health workers (CHWs) in improving health outcomes. The faculty will review strategies for integrating CHWs into clinical teams, effective communication and collaboration with CHWs, and best practices for supervision and training. Participants will also learn about the potential benefits and challenges of integrating CHWs into the clinical workforce. By participating in this webinar, healthcare professionals will gain the necessary skills to effectively collaborate with CHWs and improve healthcare access and outcomes for their patients.
Release Date: July 20, 2023
Expiration Date: July 20, 2024
UAN: JA4008162-9999-23-283-L99
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Educational Objectives
After completing this activity, the participant should be better able to:
- Describe the role of community health workers in improving healthcare access, health outcomes, and health equity.
- Identify the essential skills, knowledge, and qualities of effective community health workers.
- Discuss the challenges and benefits of integrating community health workers into healthcare teams.
- Describe how to collaborate and communicate effectively with community health workers to achieve shared goals.
- Discuss strategies for integrating community health workers into healthcare teams.
- Explain the importance of cultural humility and sensitivity in working with diverse populations.
- Identify best practices for building cultural responsiveness among healthcare teams.
Faculty
Mellanese Alexander CCHW
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenter has nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
**This course is no longer offering CE credits.**
After completing this activity, the participant should be better able to:
- Recognize the stages of syphilis.
- Identify syphilis screening recommendations for specific populations.
- Explain syphilis testing procedures and algorithms.
- Describe syphilis prevention and treatment recommendations.
The Telehealth Institute I features presentations from four programs that have engaged priority populations in virtual HIV prevention and care services. Telehealth increases access to care by reducing barriers such as time, stigma, and transportation. The presentations in the Telehealth Institute include live, two-way virtual care, smartphone apps, and virtual communities of practice, in both rural and urban communities.
Learning Objectives:
Identify telehealth applications for HIV prevention and care services for priority populations.
Describe how telehealth reduces barriers to HIV prevention and care in both rural and urban communities.
Explain common challenges and solutions to telehealth implementation across various virtual models of care.
The Telehealth Institute II features presentations from three programs that have engaged priority populations in virtual HIV prevention and care services. Topics highlighted within these presentations cover topics related to utilizing telehealth promotions and communication tactics, data tools, and mHealth to reach a variety of differing priority populations. Identify non-traditional ways to communicate health information to at-risk populations. Describe how telehealth programs can be culturally tailored to the populations they serve. Describe how mHealth interventions can be adapted to address language and HIV support barriers
Learning Objectives:
*This course no longer offers CE credits.*
Please review the content below at your own pace.
Release Date: May 11, 2023
Target Audience:
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Faculty: Gretchen Cruz Figueroa, PsyD
Educational Objectives:
After completing this activity, the participant should be better able to:
- Identify at least three common mental health challenges that children, adolescents, and young adults face when living with HIV.
- Describe how mental health challenges can impact medical care and treatment.
- Describe at least three ways to address the particular mental health challenges that children, adolescents, and young adults living with HIV face in order to improve their self-perceived health and reception of medical treatment.
**This course is no longer offering CE credits.**
Please review the content below at your own pace.
Educational Objectives:
- Identify the psychobiosocial/multiple meanings process model of addiction supporting integrative harm reduction psychotherapy (IHRP).
- Describe harm reduction’s core principles.
- Explain an overview of IHRP’s seven therapeutic tasks.
This session provides participants with an overview on primary PrEP care and the challenges providers can face with access, adherence, and retention in Black, Indigenous, and people of color (BIPOC) communities.
Faculty: Dr. Tyris Ford, DNP, NP-C, FNP-BC, AAHIVS
Learning Objectives:
- Explain the importance of increasing PrEP utilization among BIPOC Communities.
- Summarize PrEP formulations and guidelines.
- Describe patient and provider concerns regarding PrEP use.
- Identify barriers and opportunities to engage and retain BIPOC communities in PrEP uptake.
NOTE: This session does NOT offer continuing education credits.
This course is jointly provided by Postgraduate Institute for Medicine (PIM) and HealthHIV.
Please review the content below at your own pace.
NOTE: If you seek continuing education credits (CEUs) from PIM after completing the module, you will go to their website and complete a post-course check and an evaluation. If you will not seek credits, you will not need to take a post-course check, but please complete the non-credit evaluation at the end of the module. Whether or not you seek credits, you do not need to take a pre-course check and can go straight to the presentation.
Release Date: August 14, 2023
Expiration Date: August 14, 2024
UAN: JA4008162-9999-23-286-L0
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Educational Objectives
After completing this activity, the participant should be better able to:
- Describe the concept of intersectionality.
- Discuss the intersections of HIV, substance use disorder (SUD), and COVID.
- Consider how to treat the whole person throughout their life course.
Faculty
Tamara A Henry Ed.D.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenter has nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This course is jointly provided by Postgraduate Institute for Medicine and HealthHIV.
Please review the content below at your own pace.
Release Date: October 19, 2023
Expiration Date: October 19, 2024
UAN: JA4008162-9999-23-351-
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Educational Objectives
After completing this activity, the participant should be better able to:
- Recognize the need for accurate and comprehensive data for the transgender community.
- Recognize the unique healthcare needs of transgender individuals.
- Describe the need for culturally and patient centered care for this population.
- Identify strategies to reduce stigma and empower the transgender community.
Faculty
Jasmine Ford LPN, BA
HIV Care Services Clinical Coordinator, VDH
Earline Budd Non Medical Case Management Specialist, HIPS
Panelists:
Sherri Meeks, Whitman-Walker
Tyree Williams, Brothers of Bonds
Kaniya Walker,
Heart to Hand
Achim Howard, Trans Men Rising
Kym Gordon, Damien Ministries
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
Kimberly Gordon has the following financial disclosure:
- Employee at Damien Ministries
Earline Budd has no relevant financial relationship(s) with ineligible companies to disclose.
Achim Howard has no relevant financial relationship(s) with ineligible companies to disclose.
Kaniya Walker has no relevant financial relationship(s) with ineligible companies to disclose.
Sherri Meeks has no relevant financial relationship(s) with ineligible companies to disclose.
Tyree Williams has no relevant financial relationship(s) with ineligible companies to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been mitigated.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 2 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 2 contact hour(s) (0.2 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 2 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 2 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 2 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This module reviews the Uniform Guidance for HHS awards as it pertains to time and effort reporting. It also describes industry practices for timekeeping.
Faculty: Jana Collins, MS
Original Publishing Date: 7/29/2021
Contact Information: HAHSTACBAPrograms@dc.gov
The Transgender Health Institute features six presentations addressing the value of stakeholder engagement, the importance of a sexual and gender minority culturally aware staff, in addition to providing a discrimination/stigma-free environment to holistically and intersectionally engage transgender and gender non-conforming (TGNC) people in services. Presentations will cover the health needs of TGNC youth and adults, the importance of pelvic health education, how to reach hard-to-test communities in the Ball/House scene, strategies for engaging transitional age youth (TAY) in services, as well as exploring the intersections of identities with trans men of color, particularly Black trans men and Black trans masculine individuals. Identify how to use stakeholder engagement, advisory committees, and community organizing to guide the development of programs, provision of services, and allocation of resources to address Transgender Health. Describe how to incorporate comprehensive, co-located, gender-affirming care efforts into practice to engage transgender and gender nonbinary (TGN) adolescents and transitional age youth (TAY). Identify tools and strategies to fight stigma in addition to resources to better serve trans people. Identify risk factors that affect transgender and gender-nonconforming people in order to recommend appropriate person-center guidance to reduce risk and improve overall health outcomes. Explore strategies to engage hard-to-test communities into HIV prevention services through community engagement in the Ballroom/House scene. Identify strategies to discuss pelvic floor health with transgender patients in a culturally and linguistically appropriate manner.
Learning Objectives:
This webinar will briefly review the new knowledge gained during the past 50 years. The faculty will describe the shifts in cultural understanding of addiction that have given rise to new research and approaches that can help reduce stigma and discrimination against people with substance use disorders.
This course is jointly provided by Postgraduate Institute for Medicine (PIM) and HealthHIV.
Please review the content below at your own pace.
NOTE: If you seek continuing education credits (CEUs) from PIM after completing the module, you will go to their website and complete a post-course check and an evaluation. If you will not seek credits, you will not need to take a post-course check, but please complete the non-credit evaluation at the end of the module. Whether or not you seek credits, you will not need to take a pre-course check.
Release Date: August 17, 2023
Expiration Date: August 17, 2024
UAN JA4008162-9999-23-287-L02-P
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
Educational Objectives
After completing this activity, the participant should be better able to:
- Identify two dimensions that underlie stigma related to addiction
- Recognize and describe the impact of stigma on patient care
- Identify three strategies that are helpful to address addiction stigma
Faculty
Dr. John F. Kelly, PhD, ABPP
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:
The faculty presenter has nothing to disclose.
The PIM planners and others have nothing to disclose. The HealthHIV planners and others have nothing to disclose.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthHIV. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Continuing Social Work Education
As a Jointly Accredited Organization, Postgraduate Institute for Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Postgraduate Institute for Medicine maintains responsibility for this course. Social workers completing this course receive 1.0 Clinical continuing education credits.
Continuing Psychologist Education
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.
Credit Designation: This program offers 1 continuing education credits for psychologists.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This course will discuss the importance and need for engagement with faith groups and organizations specifically within the Latino/a/x community. There will be an exploration of the existing Latino/a/x focused faith groups and organizations in the Maryland area. Various resources will be shared that will inform both the personal assessment process as well as the development of either personal or organizational Strategic Religious Engagement plans. At the conclusion of the training, participants will be armed with tools to effectively form collaborative relationships with diverse Latino/a/x faith groups and organizations in order to further their HIV prevention work.
Faculty: Amalia Amy Zamot, MS, HRC
Target Audience: Clinical Staff, Community Health Workers, HIV Case Managers, Nurse Practitioners/APRN, Pharmacists, Physician Assistants, Physicians, Providers, Psychologists, Registered Nurses, Social Workers
Learning Objectives:
- Define Strategic Religious Engagement and other key terms inherent within diverse faith cultures
- List at least three prevalent faith groups within the Latinx community
- Discuss common challenges at the intersection of Faith and HIV
- List at least three resources for ongoing engagement capacity development
- Develop a Strategic Religious Engagement plan
NOTE: This module does NOT award credits.
Healthcare providers have continued to experience worsening mental health symptoms, which can be exacerbated during the holiday season. This offering reimagines mental health as an essential component of whole-body wellness, identifies coping strategies to re-set, refocus and refresh, and provides an understanding of people-centered resources.
Faculty: Ebony Johnson, A Drop of Prevention
Learning Objectives:
1. Examine the importance of mental health in expanding providers' overall health and quality of life
2. Explore communication tools, self-care strategies, and coping techniques to counter holiday stressors
3. Identify community and workplace resources to reduce stress, improve mental health, and provide healthy options for self-care
NOTE: This module does NOT award credits.
Session #1: Session Title: The intersection of Health Literacy, and Women’s Health: Leveraging our Experience and Research to Improve Health Outcomes Session Description: Session Learning Objectives: Describe successful methods to increase health literacy skills for women living with HIV. Discuss strategies for effective intervention for PrEP uptake in Black women. Understand similarities that exist between cisgender, transgender women of color that increase risk for HIV. Discuss frameworks to promote health and foster cross-sector collaborations to improve outcomes. Describe effective ways to increase HIV education tailored for Black women. Session #2: Session Title: Creating a Circle of HIV Care for Women Session Description: Session Learning Objectives: Discuss specific barriers and challenges to engaging women in HIV Care Identify models for effective virtual support groups to improve health outcomes for HIV-Positive transgender and cis Women Understand the components of client centered goals that promote engagement in care Session #3: Session Title: The Invisible Community of Women Ending the Epidemic Session Description: Session Learning Objectives: Discuss the intersectionality of power, and criminalization of women’s bodies Identify advocacy messaging on issues impacting stigmatization of Black women Describe health disparities and risk factors among Black lesbian and queer women and girls Identify patient-centered preventative care models Understand the importance in perinatal mental health training for mental health providers
Health Literacy can be catalyst to improving the health of women regardless of HIV status. In this track session we will display how the use of different vehicles to increase knowledge and empower critical skills to reduce health disparities for women. Establishing initiatives that share real stories and promote discussion will bridge women to work together to increase knowledge, attitudes and beliefs about HIV, PrEP and retention in care. Lastly, we will explore strategies to improve health models that increase engagement in research and advocacy.
Women living with HIV (WLWH) face unique challenges when it comes to care and treatment. The existing models of care must consider the degrees in which women engage and process information. This session will expound on the impact of well-designed virtual support groups on engagement of care, medication adherence, and emotional and behavioral health. We will also address how to scale interventions across multiple populations of women.
This conference session will challenge mindsets and belief around how systems change. Witness how women take the lead on advocating for healthy and whole living and how they leverage power dynamics to work in their favor. Many laws around women of color impede reproductive and sexual freedom instead of providing justice through protection and empowerment. Lack of access to culturally appropriate perinatal healthcare for Black women further increases health disparities Navigation of healthcare for black lesbian and queer women and girls can be a very daunting process resulting lack medical and behavioral health. Focus groups and survey finding show need for increased efforts to decrease barriers to sexual freedom and reproductive health for Black women.
Workplace systems can cause burnout among healthcare professionals. A range of societal, cultural, structural, and organizational factors contribute to burnout among the healthcare workforce. Some examples include: excessive workloads, administrative burdens, limited say in scheduling, and lack of organizational support.
This module provides strategies to break the burnout cycle and techniques to reinforce and nurture self-care for the healthcare workforce.
Learning Objectives:
At the end of this session, you will be able to:
- Identify systemic and structural elements that can support workplace satisfaction.
- Describe strategies, tools, and resources that promote mental health and support self-care.
- Explain methods for transforming workplace culture and building community support.
- Review how to set professional boundaries.
Faculty: Ebony Johnson MHS
NOTE: This module does not offer continuing education credits.